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ABSTRACT 
 
Christopher Joseph O’Conor: TRPV4-mediated mechanotransduction in articular cartilage 
function and disease. 
(Under the direction of Farshid Guilak and Elizabeth Loboa) 
 
 
 
Osteoarthritis (OA) is a debilitating and painful disease of synovial joints that affects 
an estimated 27 million people in the United States. Limitations to current treatments include 
the ineffectiveness of conservative treatments, as well as the risks, costs, and limited life-
span of surgical interventions. The progressive joint degeneration of OA involves the 
modulation of cartilage extracellular matrix metabolism towards degeneration. Mechanical 
loading is known to play a central role in cartilage function, both in the normal and 
pathological settings. This dissertation provides important insights into how mechanical 
factors the influence the function of articular chondrocytes in ways that are relevant to 
cartilage maintenance and disease. 
The transient receptor potential vanilloid 4 (TRPV4) ion channel is implicated in 
chondrocyte mechanical signal transduction via changes in tissue osmolarity. This 
dissertation characterizes the role of TRPV4 in cartilage maintenance during both normal and 
abnormal loading. The physiologic effects of dynamic compressive loading on chondrocyte 
function are examined with regard to TRPV4-mediated mechanical signal transduction. The 
role of TRPV4 in obesity model of osteoarthritis and stem cell differentiation potential is also 
examined. Lastly, an investigation into the role of TRPV4, specifically in articular cartilage, 
in destabilization-induced osteoarthritis is detailed. The results presented in this dissertation 
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that describe the mechanical regulation of chondrocyte metabolism via TRPV4-mediated 
Ca2+ signaling are predicted to contribute to the development of novel pharmaceutical and 
biophysical interventions for the treatment of osteoarthritis.  
 
 
 
  - v - 
I dedicate this thesis to my mother, my sister, and my wife. 
  - vi - 
ACKNOWLEDGEMENTS 
 
I would like to acknowledge my family for their continued support throughout this  
 
long, rewarding, educational marathon. My advisor, Farshid Guilak, a limitless source of  
 
support and guidance, thank you for pushing me to be the best scientist and person I can be. 
 
The work of Holly Leddy, Amy McNulty, Natasha Case, and Bridgette Furman, and their 
 
willingness to serve as role models, mentors, and collaborators, provided a foundation on 
 
which to formulate and execute this work. I have also had the pleasure to work alongside 
 
both an outstanding Pratt Fellow in Halei Benefield, as well as an equally remarkable  
 
Howard Hughes Medical Research Fellow Hari Ramalingam, for whose contributions I am  
 
incredibly grateful. I also want to acknowledge Bob Nielsen, Steve Johnson, and Elaine  
 
Campbell, for their behind-the-scenes work that kept this project going. 
 
Thanks to Gene Orringer and the rest of the MD/PhD Program for giving me the  
 
opportunity and support to pursue my true passions. I am exceptionally thankful for the  
 
support from both the NIH Medical Scientist Training Program (T32) and the NIH Ruth L.  
 
Kirschstein National Research Service Award (F30), which has allowed me the personal and  
 
scientific development necessary to complete the work contained in this dissertation. 
  - vii - 
TABLE OF CONTENTS 
 
TABLE OF CONTENTS ....................................................................................................... viii 
LIST OF TABLES ................................................................................................................... ix 
LIST OF FIGURES ................................................................................................................. ix 
LIST OF ABBREVIATIONS .................................................................................................. xi 
CHAPTER 1. INTRODUCTION ............................................................................................. 1 
1.1. ARTICULAR CARTILAGE ......................................................................................... 1 
1.2. OSTEOARTHRITIS ...................................................................................................... 2 
1.2.1. Epidemiology and Pathogenesis ............................................................................. 2 
1.2.2. Treatments ............................................................................................................... 4 
1.3. CARTILAGE MECHANOTRANSDUCTION ............................................................ 4 
1.3.1. Osmo-mechanotransduction ................................................................................... 4 
1.3.2. Mechanically-influenced Osteoarthritis .................................................................. 6 
1.4. TRANSIENT RECEPTOR POTENTIAL VANILLOID 4 ........................................... 7 
1.4.1. The TRPV4 Ion Channel ........................................................................................ 7 
1.4.2. TRPV4 in Articular Chondrocytes .......................................................................... 8 
1.5. IN VITRO MODELS OF CARTILAGE MECHANOTRANSDUCTION .................. 9 
1.5.1. Biophysical signal generation during dynamic loadings ...................................... 10 
1.5.2. Candidate structures for biophysical signal transduction ..................................... 15 
1.6. ANIMAL MODELS OF OSTEOARTHRITIS ........................................................... 17 
1.7. DISSERATION SCOPE AND OBJECTIVES ............................................................ 20 
  - viii - 
CHAPTER 2: TRPV4-MEDIATED CHONDROCYTE MECHANOTRANSDUCTION ... 22 
2.1. INTRODUCTION ....................................................................................................... 22 
2.2. MATERIALS AND METHODS ................................................................................. 24 
2.3. RESULTS .................................................................................................................... 28 
2.4. DISCUSSION .............................................................................................................. 38 
CHAPTER 3. TRPV4 IN OBESITY-ASSOCIATED OSTEOARTHRITIS ......................... 44 
3.1. INTRODUCTION ....................................................................................................... 44 
3.2. MATERIALS AND METHODS ................................................................................. 45 
3.3. RESULTS .................................................................................................................... 48 
3.4. DISCUSSION .............................................................................................................. 51 
CHAPTER 4. THE ROLE OF TRPV4 IN A MODEL OF INSTABILITY-INDUCED  
OSTEOARTHRITIS ............................................................................................................... 56 
4.1. INTRODUCTION ....................................................................................................... 56 
4.2. MATERIALS AND METHODS ................................................................................. 57 
4.3. RESULTS .................................................................................................................... 60 
4.4. DISCUSSION .............................................................................................................. 63 
CHAPTER 5. CONCLUSIONS ............................................................................................. 65 
5.1. TECHNIQUES AND FUTURE DIRECTIONS ......................................................... 65 
APPENDIX A. ........................................................................................................................ 69 
REFERENCES ....................................................................................................................... 70 
  - ix - 
LIST OF TABLES 
 
Table 1: Porcine PCR Primer sequences ................................................................................ 68	  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  - x - 
LIST OF FIGURES 
 
Figure 2.1: Photograph of the custom loading bioreactor ...................................................... 26	  
Figure 2.2: TRPV4 function in agarose-embedded chondrocytes. ......................................... 30	  
Figure 2.3: Loading without pre-culture ................................................................................. 31	  
Figure 2.4: Gene expression with pre-culture ......................................................................... 33	  
Figure 2.5: TRPV4-mediated biosynthesis with dynamic loading ......................................... 34	  
Figure 2.6: TRPV4-dependent gene expression ..................................................................... 35	  
Figure 2.7: Two weeks of daily dynamic and quasi-static osmotic loading ........................... 36	  
Figure 2.8: TRPV4 activation via daily osmotic loading or GSK101 .................................... 37 
Figure 2.9: TRPV4 activation enhances matrix synthesis ...................................................... 38	  
Figure 3.1: Trpv4-/- mice exhibit increased adiposity in response to high-fat feeding ........... 49	  
Figure 3.2. Trpv4-/- mice have more severe diet-induced osteoarthritis 
and altered chondrocyte histomorphology. ................................................................. 50	  
Figure 3.3: Adult stem cells from Trpv4-/- mice exhibit altered differentiation potential ...... 51	  
Figure 4.1: Cartilage-specific TRPV4 knockout .................................................................... 60	  
Figure 4.2: TRPV4 cKO produces little changes in body composition .................................. 61	  
Figure 4.3: Osteoarthritis progression and synovial inflammation in  
TRPV4 cKO mice following DMM. .......................................................................... 62 
Figure 4.4: Bone changes with microCT analysis .................................................................. 63
  - xi - 
LIST OF ABBREVIATIONS 
 
OA  Osteoarthritis 
TRPV4 Transient Receptor Potential Vanilloid 4 
ECM  Extracellular matrix 
PCM  Pericellular matrix  
MMP  Matrix metalloproteinase 
ADAMTS5 a disintegrin and metalloproteinase and thrombospondin motif 
COMP  Cartilage oligomeric protein 
s-GAG  Sulfated Glycosaminoglycan 
NOS2  Nitric oxide synthase 2 (inducible) 
microCT X-ray Microcomputed tomography 
TGFβ  Transforming Growth factor beta  
ACAN  Aggrecan 
COL2A1 Collagen type II, alpha 1 
MSC  Mesenchymal stem cell 
ASC  Adipose-derived stem cell 
DMM  Destabilization of the Medial Meniscus 
  - xii - 
Cre  Cyclic recombinase 
RT-PCR Real time polymerase chain reaction 
EY  Young’s modulus 
G*  Dynamic modulus
 
CHAPTER 1. INTRODUCTION1 
 
 
 
1.1  ARTICULAR CARTILAGE 
Articular cartilage, the avascular connective tissue that covers diathrodial joints, 
provides a near frictionless surface to support and distribute mechanical loads generated 
during movement and locomotion.  
A large fraction of articular cartilage is water and dissolved ions (70-80% of wet 
weight), followed by an extracellular matrix (ECM) component (20-30%), which gives 
cartilage its material and functional properties, and a sparse population of chondrocytes (~1-
2%), the cells of articular cartilage [1]. The ECM of articular cartilage is primarily composed 
of type II collagen (12-18% wet weight) and proteoglycans (5-10% wet weight) [1-3]. Large 
fibers of type II collagen provide tensile strength, while proteoglycans, dense with fixed 
negative charges, attract counter ions and water that swell the tissue. Although chondrocytes 
exhibit little division or repopulation, healthy cartilage exhibits regular matrix turnover via a 
balance of anabolic and catabolic processes. For example, the half-life of matrix components 
range from ~11 days for proteoglycans [4] to ~100 years for collagens [5]. Importantly, the 
composition and structure of cartilage varies with depth, location in the joint, and distance 
from chondrocytes. In particular, the pericellular matrix (PCM) of articular cartilage, which 
surrounds the chondrocyte, is rich in type VI collagen, as well as proteoglycans such as 
                                                
1 Portions of this chapter previously appeared as an article in Stem Cells Research & Therapy. The original 
citation is as follows:  O’Conor CJ, Case N, Guilak F. “Mechanical Regulation of Chondrogenesis.” Stem Cells 
Research & Therapy, 4(4):61 (2013). 
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fibronectin, aggrecan, and decorin. The lower Young’s modulus and hydraulic permeability 
of the PCM relative to the ECM also leads to a unique biochemical and biophysical 
environment, particularly during compressive loading. Specifically, the PCM modulates the 
stress-strain field and the flux of water and other molecules during compressive deformation 
[6].  
Unlike most tissues that a) contain a dense cell population, b) maintain regular cell 
turnover, and c) receive nutrients and other reparative factors from a blood supply, fully 
matured articular cartilage is a) sparely populated with chondrocytes, b) undergoes limited 
cell proliferation and migration, and c) is avascular. As such, resident chondrocytes are 
chiefly responsible for regulating the maintenance and repair of articular cartilage, with the 
latter being remarkably limited. 
 
1.2  OSTEOARTHRITIS 
1.2.1 Epidemiology and Pathogenesis 
Osteoarthritis (OA), the most common form of arthritis, is defined by the progressive 
and painful degeneration of the articular cartilage and surrounding joint tissues. OA is a very 
prevalent disease, affecting an estimated 27 million Americans, or more than 10% of the total 
United States adult population, and is the fourth most common cause of hospitalization [7]. 
Diagnosing OA can be difficult in the early stages of the disease and is often diagnosed after 
the disease has progressed. Clinical diagnosis of OA can be based solely on patient history 
and physical examination, but typically is used in combination with radiographic evidence to 
guide patient care. While OA is most commonly associated with aging, with a 10 fold 
increase in prevalence from age 30 to age 65 [8], the development of OA can often be multi-
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factorial. Risk factors for OA, such as trauma, dysplasia, impingement, inflammatory and 
metabolic diseases, obesity, gender, occupation, and destabilization of the joint (typically due 
to an injury to the surrounding menisci, ligaments, and capsules), are all known to initiate 
and/or accelerate the progression of OA [9]. However, joint use is not uniformly a risk factor 
for OA. For example, moderate levels of daily physical exercise are protective against the 
development of cartilage defects [10]. Thus, joint loading is capable of playing both a 
chondroprotective and chondrodegenerative role. 
Though the progression of OA can vary, the initial stages of OA include the enhanced 
proteolytic breakdown of cartilage ECM via matrix metalloproteinases (MMPs) and 
members of the family of a disintegrin and metalloproteinase and thrombospondin motifs 
(ADAMTSs). This results in proteoglycan loss, increasing tissue water content and 
decreasing the osmolarity of the tissue, though the concentration of collagen typically 
remains constant. With further disease progression, fibrillation and erosion of the surface 
zone begins to occur, releasing cartilage fragments into the joint space. During this process, 
chondrocytes respond by enhancing both anabolic and catabolic ECM metabolism [11], 
though this response is typically insufficient to restore the tissues original properties. 
Chondrocyte morphology also changes during OA progression, with the appearance of cell 
hypertrophy in the middle and deep zones, as well as cell proliferation, resulting in 
chondrocyte clustering. Osteoarthritis progression also often involves a response of peri-
articular tissues, including synovial inflammation and hyperplasia, subchondral bone 
thickening and osteophyte formation. 
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1.2.2 Treatments 
The early treatments for OA are quite limited, and include pain relief in the form of 
analgesics and anti-inflammatory drugs. Low impact physical activity such as walking or 
swimming has also been shown to decrease pain, improve function, and improve the moods 
of symptomatic OA patients, as has self-management education [7]. Reducing comorbidities 
such as obesity also improves the outcomes of OA patients [12]. Patients with advanced OA 
can benefit from surgical intervention, often in the form of total joint arthroplasty, or joint 
replacement. OA is the most common indication for joint replacement, with almost one 
million knee and hip replacements performed in the US each year. While effective, these 
replacements have a limited effective lifespan necessitating complex revision surgery, and 
are costly, at $42.3 billion dollars per year [7]. Better, disease-modifying treatments at the 
earlier stages of OA to prevent the development and progression of OA have the potential to 
greatly improve patient morbidity and reduce the overall healthcare burden. 
 
1.3 CARTILAGE MECHANOTRANSDUCTION 
1.3.1 Osmo-mechanotransduction 
Joint loading regulates cartilage ECM metabolism and tissue homeostasis by the 
transduction of compressive loading into intracellular signals within chondrocytes [13, 14]. 
However, the mechanism(s) by which these mechanical signals are transduced and 
interpreted by the cells is poorly understood. The main mode of mechanical stimulation 
during joint loading is compression, with an additional component of shear stress due to the 
flow of synovial fluid over the surface of the cartilage. The compressive stiffness of articular 
chondrocytes is on the order of 1 kPa, or approximately 1/40th the stiffness of the 
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surrounding PCM and ~1/400th the stiffness of the ECM [6]. This variation results in strain 
amplification of the PCM and cell relative to the bulk tissue. The overall low permeability of 
cartilage also generates an initial hydrostatic pressurization of the tissue of up to 10 MPa 
[15]. As the tissue equilibrates, water is driven out of the tissue, causing fluid flow and shear 
stress fields within the tissue, while at the same time lowering the osmolarity of the tissue. 
Thus, the four main biophysical factors generated during cartilage loading are deformation, 
fluid shear stress, and hydrostatic and osmotic pressurization [16].  
One particular mechanism of cartilage mechanotransduction, involving osmolarity, 
has been proposed: compression of the cartilage ECM during joint loading, causing 
preferential exudation of water (followed by passive resorption upon unloading), leads to 
fluctuations in tissue osmolarity [13], causing changes in chondrocyte intracellular Ca2+ [17, 
18] which in turn regulates the metabolic function in chondrocytes, including ECM gene 
expression and inflammatory cytokine production [19, 20]. There are numerous mechanisms 
by which intracellular calcium signaling may affect chondrocyte function. Ca2+ signaling is 
known to modulate many signaling pathways, including nuclear factor of activated T 
lymphocytes (NFAT), Protein kinase C, nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB), c-Jun N-terminal kinase 1 (JNK1), and cAMP response element-
binding protein (CREB) pathways [21]. Downstream of these pathways may also be 
pathways relevant to chondrocytes, such as Sox9 [22] and Smad signaling [23], inflammatory 
mediators, and ECM gene expression [22]. 
Depending on the particular loading regime, it is possible to elicit a variety of 
physiologic responses in the articular cartilage. Moderate levels of cyclic compression 
typically generate an anabolic and anti-catabolic response, including increased aggrecan, 
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collagen type II, and cartilage oligomeric protein (COMP) expression [24-26] and sulfated 
glycosaminoglycan (s-GAG) biosynthesis, and decreased ADAMTS5, nitric oxide synthase 2 
(NOS2) and MMP expression [27]. In contrast, non-physiologic loading, such as static and 
high magnitude loading, can produce deleterious effects on cartilage health, such as cell 
death, tissue swelling, and tissue catabolism. Mechanistic studies have implicated effectors, 
such as MMPs, aggrecanases, and cyclooxygenase expression in this response [28, 29]. 
1.3.2 Mechanically-influenced Osteoarthritis 
Though historically thought to be an unavoidable process associated with advanced 
age, OA is now recognized to be a product of a complex interplay between biochemical and 
biomechanical factors [30-32] that cause an imbalance in anabolic and catabolic signaling 
pathways in joint tissues [33, 34]. For example, obesity increases the propensity for OA 
development [35], and appears to relate to both the obesity-associated changes joint 
biomechanics and loading, as well as to the heightened levels of adipokines [36]. Damage to 
the stabilizing ligaments and menisci of the knee also predisposes individuals to knee OA 
[37], also involving both biomechanical and inflammatory elements. Though there remains 
an imprecise understanding of how and why these risk factors encourage joint degeneration 
and OA, it is clear that a chondrocyte-mediated response to the altered tissue loading is a 
major contributing factor to the development of these mechanically-related etiologies of OA 
[38, 39]. Through there are limited preventative treatments to attenuate this increased risk for 
mechanically-induced OA [40, 41], a precise understanding of how chondrocytes, in both 
healthy and disease-prone states, respond to their physical environment to affect cartilage 
tissue properties could provide insight into the etiopathogenesis of mechanically-influenced 
OA progression and, furthermore, lead to therapies to mitigate the risk of further OA 
  - 7 - 
progression. 
 
1.4  TRANSIENT RECEPTOR POTENTIAL VANILLOID 4 
1.4.1 The TRPV4 Ion Channel  
Transient Receptor Potential (TRP) cation channels serve as polymodal sensors in 
mammalian cells and come in six subtypes: TRPC (“canonical”), TRPV (“vanilloid”), TRPM 
(melastatin”), TRPP (“polycystin”), TRPML (“mucolipin”), and TRPA (“ankyrin”). All TRP 
gene products are intrinsic membrane proteins with six transmembrane domains, a cation 
pore region between domain 5 and 6, and intracellular amino and carboxy termini involved in 
regulating channel function and trafficking. Functional TRP channels consist of four similar, 
and often homologous, TRP subunits. Importantly, TRP channels have been found to not 
only function as biological sensors, but play important roles various homeostatic functions 
across organ systems [42]. 
 TRPV1-4 are non-selective, thermosensitive cation channels. TRPV4 was the first 
osmotically activated channel described in vertebrates [43, 44]. Mammalian TRPV4 
homologues share a high level of sequence similarity (∼95–98%). The full length TRPV4 
protein consists of 871 amino acids comprising intracellular N- and C-termini and six 
transmembrane spanning α-helical domains, as well as multiple intracellular ankyrin repeats 
and a calmodulin binding domain [45]. TRPV4 also associates with cytoskeletal elements 
microtubule-associated protein 7 (MAP7) and F-actin [46, 47]. In addition to chondrocytes, 
TRPV4 is expressed in many other cell types, including epithelial and endothelial tissues and 
the synovial lining of articular joints, as well as the somatosensory system, the renal system, 
and bone [48-54]. Though originally identified as an osmotically activated channel, TRPV4 
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can be activated and/or modulated by factors such as mechanical pressure, heat, 
inflammatory cytokines and eicosanoids [49, 55-59]. In addition to physiologic stimuli, 
pharmacologic agonists/antagonists have been developed that specifically target TRPV4 
activation, such as GSK1016790A (GlaxoSmithKline, Inc.), a TRPV4 agonist, and GSK205 
(GlaxoSmithKline, Inc.), a selective inhibitor of TRPV4 [60]. 
1.4.2 TRPV4 in Articular Chondrocytes 
TRPV4 plays a key role in controlling the response of chondrocytes to osmotic 
changes. Hypo-osmotic treatment activates TRPV4 in chondrocytes, allowing an influx of 
Ca2+ to occur, followed by the release of intracellular Ca2+ stores [60]. TRPV4-mediated Ca2+ 
influx upregulates Sox9 expression, a transcription factor which functions as a master 
regulator of chondrogenesis in chondroprogenitor cell lines [22]. In the same study, Trpv4 
gene expression was also found to correlate precisely with the aggrecan and collagen II gene 
expression profiles during chondrogenesis. Functional mutations of TRPV4 disrupt normal 
skeletal development, including endochondral ossification, as well as joint health in maturity 
[45, 61-63], signifying the importance of TRPV4-mediated signaling in the proper 
development and function of the musculoskeletal system. 
Gross examination of the effect of global Trpv4 deletion on idiopathic OA in vivo has 
been evaluated by histologic evaluation and microcomputed tomography (microCT). Male 
Trpv4-/- mice exhibit a significant loss of proteoglycan content at nine months, and by 12 
months, severe osteoarthritic changes including fibrillation and ulceration, compared to wild 
type controls is observed. Importantly, microCT revealed bony changes in male Trpv4-/- 
mice, including increased subchondral bone mass and meniscal volume [64], which may 
have contributed to the accelerated joint degeneration in this strain. Trpv4 mRNA expression 
  - 9 - 
decreases in human osteoarthritic cartilage, also pointing to a potential involvement of 
TRPV4 in human OA development and progression [61]. 
 
1.5 IN VITRO MODELS OF CARTILAGE MECHANOTRANSDUCTION 
There is growing interest in understanding the mechanobiology of not only 
chondrocytes, but multipotent stem cells as well, also capable of synthesizing cartilage-like 
tissues. These cells are abundant, expandable, available from various tissue depots including 
bone marrow, fat, and synovium [65-67], and provide a potential cell source for the 
regeneration and replacement of damaged articular cartilage resulting from injury or diseases 
such as osteoarthritis [68-71]. MSCs and chondrocytes have also been found to respond 
similarly to mechanical stimulation [17], suggesting that a similar mechanism of 
mechanotransduction may exist in these two cell populations. However, an effective cell-
based tissue replacement requires a stably differentiated cell population capable of producing 
and maintaining a functional neo-tissue. There is great interest in leveraging native 
mechanical and biophysical cues to enhance the current strategies for stem cell-based 
cartilage tissue repair. 
 Joint loading leads to complex cartilage tissue strains, including components of 
compression, tension, and shear, producing direct cellular and nuclear deformation [72]. In 
addition, indirect biophysical factors are also generated, as a result of the exudation of 
interstitial water and ions from cartilage, including streaming potentials, changes in local pH 
and osmolarity, and hydrostatic pressure [73]. Cartilage explant models have yielded 
valuable insights into biological signaling mechanisms of cartilage mechanotransduction 
[74]. However, limitations to this methodology include the inhomogeneity, anisotrophy, and 
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site-to-site variability of the extracellular matrix, and a sparse, non-homogenous cell 
population. 
 Cell-scaffold models, where enzymatically-isolated chondrocytes are embedded into 
three-dimensional scaffolds (e.g. agarose, alginate, collagen), have been widely utilized to 
study the nature of cartilage mechanotransduction. Cell-scaffold models typically utilize a 
pool of cells from full-thickness tissue digests, although it is possible to separately isolate the 
top, middle, and deep zones to study the nature of these distinct populations. Primary 
chondrocytes maintain a stable chondrogenic phenotype in 3D culture, and can produce an 
appreciable amount of functional matrix [75, 76] even in the absence of growth factors or 
serum [77, 78]. While application of dynamic compression to isolated chondrocytes or 
mesenchymal stem cells seeded into hydrogels or polymeric scaffolds will recapitulate many 
of these biophysical changes that occur in native cartilage, it is important to understand that 
the amount of extracellular matrix relative to the original scaffold or hydrogel present within 
the constructs, as well as the mechanical properties of these scaffolds, will influence the 
range of biophysical stimuli generated by loading. 
1.5.1 Biophysical signal generation during dynamic compression 
Deformation. Mechanical loading of hydrogel scaffolds results in the transmission of 
strains to cells embedded within such constructs [76, 79]. The relationship between ECM and 
cell-level strains in agarose-laden chondrocytes is also comparable to that of in situ 
chondrocytes in loaded cartilage explants [80] once a pericellular matrix has been elaborated. 
A 20% strain of day 0 chondrocyte-laden agarose constructs produce a supra-physiological 
strain in chondrocytes due to the low modulus of agarose at day 0. However, this response is 
largely attenuated with pre-culture [76] due to pericellular matrix accumulation over time in 
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culture. Deformation experiments can be done both in monolayer culture, most often by 
cyclic stretch on flexible tissue culture plates, as well in 3D agarose culture, most often using 
compressive loading. Cyclic stretching in monolayer is known to alter ion channel 
expression, including “big” potassium channel (BK) [81], with TRPV4 expression not being 
altered in this setting. In chondrocyte-agarose cultures, a mechanical threshold for cell death 
has been observed, as well as the protective effects of the neo-pericellular matrix [82]. 
Specifically, chondrocyte death is a positively correlated with both magnitude and duration 
of straining. While 5 hours of 20-25% construct strain leads to over 10% cell death in 1 day 
old constructs, additional days abolished the strain-induced cell death.  
Hydrostatic Pressure. While peak physiologic levels of fluid pressurization in 
articular cartilage are on the order of 10-20 MPa [83, 84], compression of agarose hydrogels 
are predicted to generate only around 0.5 kPa of hydrostatic pressure, due to the scaffold’s 
high porosity [85]. However, with sufficient matrix elaboration, the fluid pressurization of 
agarose cylinders subjected to dynamic compressive loading [86] is predicted to resemble the 
increase in native loaded cartilage [87].  Nonetheless, fluid pressurization, even at high 
levels, is expected to induce little or no deformation of tissues and cells, due to the intrinsic 
incompressibility of water and the cartilage extracellular matrix [88]. To evaluate fluid 
pressurization as an isolated mechanical stimulus, in vitro bioreactors have been developed 
that directly pressurize the culture medium surrounding cell-seeded constructs, in the absence 
of cell or tissue deformation [15]. Alternatively, bioreactors can pressurize the gas phase 
above the culture medium, but one limitation of these types of bioreactors is that the partial 
pressures of gas in the culture medium are affected, and thus these bioreactors are less 
commonly used. Studies using systems that directly pressurize the culture medium have 
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shown that isolated chondrocytes are responsive to hydrostatic pressure. Acute application of 
static hydrostatic pressure at 5 MPa for 4 hours enhanced Col2α1 and aggrecan expression 
by chondrocytes in agarose gels [89], while application of both dynamic and static 
hydrostatic pressure at 10 MPa to scaffoldless chondrocyte constructs for 1 hour/day on days 
10-14 of culture led to increased sGAG production and compressive stiffness at day 28 [90].    
           Applying dynamic hydrostatic pressurization (3-10 MPa, 1Hz) to human MSCs either 
seeded within scaffolds or in pellet culture in the presence of transforming growth factor beta 
(TGFβ) increased expression of cartilage extracellular matrix genes and enhanced 
biochemical content compared to TGFβ alone [91-93]. In these studies, hydrostatic pressure 
was applied by directly pressurizing the culture medium for 1-4 hours/day beginning in the 
first week of culture, indicating that the MSC response to hydrostatic loading does not 
require a pre-culture period. Miyanishi et al. examined dose dependency of hydrostatic 
loading with TGFβ supplementation, and found that while 0.1 MPa was sufficient to increase 
Sox9 expression, upregulation of Col2α1 gene expression only occurred with loading at 10 
MPa [94]. Hydrostatic pressure also transiently increased cartilage-associated genes in the 
absence of TGFβ [92, 95, 96]. Additional studies with rat MSCs cultured in alginate applied 
hydrostatic pressure following an initial 8-day pre-culture in chondrogenic medium including 
TGFβ. Dynamic hydrostatic pressure applied by pressurization of the gas phase above the 
culture medium for 7 days at 13-36 kPa and 0.25 Hz, parameters lower than in previous 
studies, increased expression of Col2α1 and aggrecan, as well as sGAG accumulation, both 
in the absence and presence of TGFβ [97, 98]. Furthermore, in the absence of exogenous 
TGFβ, hydrostatic pressure increased expression and secretion of TGFβ1, as well as the 
phosphorylation of Smad2/3 and p38 MAP kinase. However, pharmacologic inhibition of 
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TGFβ signaling only modestly reduced the upregulation of Col2α1 by loading and had no 
influence on the upregulation of aggrecan (ACAN) by loading, suggesting the involvement 
of other signaling pathways in mediating the response to hydrostatic pressure [98]. 
Osmotic Pressure. Healthy articular cartilage has an interstitial osmolarity ranging 
from 350 to 450 mOsm, due to the high concentration of negatively charged proteoglycans in 
the tissue, which attracts counterions [13]. Extracellular matrix production by articular 
chondrocytes has been shown to be sensitive to the medium osmolarity. Culture for 48 hours 
in 550 mOsm medium increased s-GAG synthesis by chondrocytes in alginate beads relative 
to culture in 380mOsm medium, while culture in 270 mOsm medium decreased s-GAG 
synthesis [99]. Chondrocytes cultured in medium at 370 mOsm for 6 days exhibited the 
greatest s-GAG accumulation and s-GAG synthesis by chondrocytes in alginate compared to 
culture in medium with either higher or lower osmolarity [100]. Longer-term studies have 
indicated that neo-tissue formation by articular chondrocytes in hydrogel systems is 
influenced by osmolarity of the culture medium, but the results have been contradictory [101, 
102]. Freshly isolated chondrocytes in alginate accumulated less s-GAG at 270 mOsm 
compared to osmolarities ranging from 380 - 550 mOsm [101], while culture-expanded 
chondrocytes produced neo-tissue with superior mechanical properties when cultured in 
agarose at 300 mOsm compared to 400 mOsm [102].  
Effects of osmolarity on extracellular matrix production may be due in part to 
regulation of the chondrocyte transcription factor Sox9. Treatment of freshly isolated 
chondrocytes from osteoarthritic human articular cartilage with hyperosmotic medium (550 
mOsm versus 380 mOsm) led to an increase in the levels of Sox9 mRNA and protein, an 
effect mediated in part by an increase in the half-life of Sox9 mRNA with hyperosmotic 
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exposure [103]. However, the level of Col2α1 mRNA and its half-life were decreased by 
exposure to hyperosmotic conditions. Hyperosmotic medium also increased phosphorylation 
of p38 MAP kinase, and induction of Sox9 mRNA by hyperosmotic treatment was disrupted 
in the presence of a pharmacologic inhibitor to p38 MAP kinase. A similar study in equine 
articular chondrocytes showed that hyperosmotic treatment had varying effects on Sox9 
mRNA levels dependent on whether treatment was applied in a static or cyclic manner and 
whether chondrocytes were from normal or osteoarthritic cartilage [104].    
In these studies with isolated chondrocytes, the osmolarity of the culture medium was 
kept constant. However, articular chondrocytes in situ are exposed to cyclic changes in 
osmolarity due to joint loading and unloading during normal daily activity. Compression of 
articular cartilage causes extrusion of water relative to solutes due to fixed charges on the 
sulfated GAG chains, which leads to an increase in tissue osmolarity. High frequency 
loading, such as walking, as well as prolonged joint loading resulting in diurnal strains [105], 
will produce a dynamic osmotic environment on the time scale ranging from seconds to 
hours, in magnitudes of 60 mOsm in the interstitial space [106], though this could be greater 
pericellular environment. Similar to hydrostatic pressure, the osmotic changes in chondrocyte 
and MSC-laden constructs in response to dynamic compressive loading should be minimal 
initially, but should increase with sGAG accumulation. Although there is evidence that 
dynamic hypotonic loading at 0.1 Hz may enhance cartilage matrix gene expression in 
chondrocytes in monolayer culture after 2 hours of loading [19], little is known regarding the 
long-term effects of dynamic or repetitive daily osmotic loading on neo-tissue matrix content 
and mechanical properties.   
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Growth and chondrogenic differentiation of mesenchymal stem cells are also 
influenced by culture medium osmolarity. High osmolarity medium (485 mOsm) reduced 
proliferation of both rat mesenchymal stem cells (MSCs) and human adipose-derived stem 
cells (ASCs) [107, 108]. Increasing the osmolarity of chondrogenic differentiation medium 
containing TGFβ by 100 mOsm enhanced Sox9, Col2α1, and aggrecan expression, as well as 
expression of the hypertrophic chondrocyte markers collagen type X and Runx2, in day 21 
monolayer cultures of human MSCs [109]. 
1.5.2 Candidate structures for biophysical signal transduction. 
The cell membrane. Ion channels expressed by chondrocytes include potassium 
channels, sodium channels, transient receptor potential (TRP) non-selective cation channels, 
and chloride channels [110]. Various ion channels in chondrocytes appear to be regulated by 
changes in osmolarity, as well as different forms of mechanical stimulation. Calcium 
signaling has also been observed in chondrocytes in response to hydrostatic pressurization 
[111] and compressive loading [112]. Changes in intracellular calcium downstream of ATP 
secretion and binding to purinergic receptors has also been proposed as a mechanical 
signaling pathway in chondrocytes [113]. Calcium signaling has been linked to the 
propagation of mechanical effects on gene expression in cartilage explants [114]. Treatment 
with nifedipine, a calcium channel inhibitor, or 4-aminopyridine, a potassium channel 
inhibitor, disrupted mechanical stimulation of s-GAG synthesis by chondrocytes in agarose, 
suggesting possible roles for calcium and potassium signaling in mediating this loading effect 
[115]. Altering the intracellular sodium and calcium concentrations using the pharmacologic 
agents oubain and ionomycin for 1 hour daily on days 10–14 of culture has also been shown 
to increase the tensile modulus of neo-tissue produced by chondrocytes from young bovine 
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donors in a scaffoldless culture system at 4 weeks of culture, providing evidence that ion 
channel regulation can also influence functional properties of neo-cartilage [116]. 
The cytoskeleton. The cytoskeleton in articular chondrocytes is primarily composed 
of actin microfilaments, microtubules, and vimentin intermediate filaments [117]. Disruption 
of actin microfilaments with cytochalasin D decreases the viscoelastic mechanical properties 
of chondrocytes [118] and alters chondrocyte nuclear deformation in response to 
compression of cartilage explants [72]. The actin cytoskeleton in articular chondrocytes has 
also been shown to undergo reorganization with osmotic stress and Ca2+ signaling [17, 19, 
60], as well as compressive loading and hydrostatic pressure [119]. These studies suggest 
that the cytoskeleton is involved in the response of chondrocytes to mechanical loading, yet 
studies directly implicating the cytoskeleton in transducing mechanical load are lacking. 
Prior work has shown that integrins are involved in responses of chondrocyte-hydrogel 
constructs to dynamic compressive loading [120, 121]. Linkages between integrins and 
cytoskeletal components are thought to be integral to mechanotransduction in various cell 
types [122], but such linkages in chondrocytes have not been well-defined. 
The primary cilium. The primary cilium is a non-motile organelle that extends from 
the cell surface and has been implicated in both sensory and signaling functions in a variety 
of cells [123]. Primary cilia were identified on articular chondrocytes more than three 
decades ago [124, 125], and recent work indicates that the primary cilium may have an 
important role in chondrocyte mechanotransduction [126, 127]. Primary cilia on sternal 
chondrocytes were shown to have α2, α3, and β1 integrins on their surface [128], allowing a 
direct linkage between the cilium and collagens in the surrounding PCM. As such, tissue 
compression during joint loading could lead to deformation of the cilium. Ion channels, 
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including TRPV4, are also found on primary cilia. Interestingly, chemical disruption of the 
primary cilia on articular chondrocytes blocked the increase in intracellular calcium caused 
by exposure to hypo-osmotic stress or a TRPV4 channel agonist [60]. Acute compressive 
loading of sternal chondrocyte-agarose disks has been shown to induce an increase in 
calcium signaling, upregulation of aggrecan expression, and higher s-GAG accumulation; 
these loading effects were absent in IFT88(orpk) mutant chondrocytes that lack primary cilia 
[129]. Together, these studies suggest that the primary cilium may contribute TRPV4-
mediated mechanical signal transduction in chondrocytes.  
The nucleus. Deformation of the nucleus in chondrocytes may be important in 
propagating the cellular response to biophysical stimuli [130]. The connections between the 
extracellular matrix, integrins, cytoskeleton, the linker of nucleoskeleton and cytoskeleton 
(LINC) complex, and nuclear lamina allow for direct transmission of biophysical forces from 
the cell exterior to the nucleus and potentially to subnuclear structures. The nucleus in 
chondrocytes deforms in response to compression of articular cartilage explants [72] and 
chondrocyte/agarose constructs [131]. Application of osmotic stress to chondrocytes also 
influences nuclear volume and structure [132], with changes in the nucleus likely reflecting 
alterations in intracellular ionic and macromolecular concentrations [133]. 
 
1.6 ANIMAL MODELS OF OSTEOARTHRITIS 
Mice are the preferred animal model to identify and study individual pathways in OA 
pathogenesis, given the large library of transgenic animals for this species and relatively low 
cost. Murine models of OA are as diverse and multifactorial as the etiologies of OA seen 
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clinically, and allow for the longitudinal evaluation of changes in synovial and systemic 
cytokine levels, behavioral and biomechanics testing, and joint microCT and joint histology.   
Models that primarily examine the inflammatory factors in OA include intra-articular 
injections of complete Freund’s adjuvant [134], as well as intra-articular fracture [135], 
which induce high levels of inflammation. In these scenarios, the biomechanical factors are 
mostly likely overshadowed by the intense and sustained inflammatory response.  
The purest biomechanical model of OA is perhaps hind limb immobilization, which 
has been used to study the effects of physiologic joint loading on cartilage metabolism and 
protection of OA pathogenesis [136]. Similar to this is treadmill exercise, which has also 
been used to study the chondroprotective effects of running during OA development [137].  
Obesity [138] and surgical joint destabilization [139] represent two models of 
osteoarthritis that are both highly similar to human OA pathogenesis, and are known to 
involve both mechanical and inflammatory factors. Like humans, induction of obesity in 
mice by a high-fat diet markedly accelerates idiopathic OA progression and severity [138, 
140]. A high fat diet in the setting of joint destabilization [141], as well as intra-articular 
fracture [142], also increases the severity of OA. This effect of obesity on OA progression 
appears to be due to multiple factors, including the specific dietary components, altered 
mechanical load due to weight changes, and the systemic level of inflammation that occurs 
with obesity.  
Surgical destabilization models include ACL transection, medial meniscectomy, and 
destabilization of the medial meniscus (DMM). DMM, currently the most widely adopted 
OA model, has proved to be very similar to human OA (proteoglycan loss, mild synovitis, 
cartilage erosion, subchondral bone sclerosis and osteophyte formation) and highly 
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reproducible [143]. In addition, this model has proven effective in identifying a number of 
disease-modifying enzymes including ADAMTS5 [144], MMP-13 [145], and PAR-2 [146]. 
 The study of individual genes in mouse models, classically performed by germline 
gene knockout, is a powerful way to assess the role of specific proteins or pathways in 
normal and pathological processes Advances in transgenic technology, specifically Cre/loxP 
and FRT/FLP, have further provided the ability to create virtually any modification in the 
genetic background, including gene insertion, point mutation, short and long deletions, and 
inversions. In the Cre/loxP system, loxP sites, consisting of two 34 bp sequences, are inserted 
via homologous recombination to flank the sequence of interest. This strain is then combined 
with an animal expressing cyclic recombinase (Cre), which provides site-specific 
recombination at the loxP sites. To reduce the time from design to execution of conditional 
knockout work, there is an international mouse knockout consortium (IKCM) whose goal is 
to compile an open library of conditional alleles for every gene (including microRNA genes) 
of the mouse genome (http://www.knockoutmouse.org/).  Further control over this system 
can be achieved by driving Cre expression in a tissue-specific fashion. For example, by using 
Col2α1 [147] or aggrecan [148] promoters to drive Cre expression, Cre expression, and thus 
recombination, is limited to chondrocytes. Furthermore, genetic manipulation can also be 
controlled temporally by making Cre expression inducible via either tamoxifen [149] or 
doxycycline [150] to limiting any potential embryonic lethality, developmental effects, or 
genetic compensation. 
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1.7 DISSERTATION SCOPE AND OBJECTIVE 
This dissertation addresses the role of TRPV4 in chondrocyte mechanotransduction, 
at both the molecular and organ system level. A tissue-engineering approach is used in 
Chapter 2 to investigate how TRPV4 participates in chondrocyte mechanotransduction. 
Chapters 3 and 4 examine the in vivo role of TRPV4-mediated mechanotransduction during 
mechanically-influnced cartilage degeneration, by studying transgenic animal models of 
TRPV4 signaling in the settings of osteoarthritis pathogenesis.  
 
Hypothesis #1: Chondrocytes respond to compressive loading via activation of TRPV4. 
Specific Aim 1: To study the role of TRPV4-mediated signaling on chondrocyte biosynthesis 
and the resulting ECM properties in response to dynamic compressive loading. My goal was 
(a) to determine the extent that TRPV4 activation is responsible for the known metabolic 
effects of cyclic compressive loading on matrix metabolism in chondrocyte-laden agarose 
constructs, (b) to compare mechanical loading the effects of loading to pharmacologic and 
osmotic TRPV4 activation, and (c) to investigate potential pathways downstream of TRPV4-
mediate Ca2+ signaling that may be involved in the mechanical regulation of chondrocyte 
matrix biosynthesis. 
 
Hypothesis #2: Loss of TRPV4 signaling exacerbates acute cartilage degeneration secondary 
to high-fat diet-induced obesity via altered stem cell differentiation potential. 
Specific Aim 2:  To examine the role of TRPV4 signaling on OA progression in the setting of 
diet-induced obesity. Our goals were to assess the effects of TRPV4 knockout on (a) diet-
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induced obesity and (b) the development of obesity-associated OA, and (b) to relate these 
findings to the role of TRPV4 signaling on stem cell differentiation potential. 
 
Hypothesis #3: Cartilage-specific deletion of TRPV4 in adult mice will prevent acute 
cartilage degeneration secondary to joint destabilization by inhibiting aberrant TRPV4-
mediated mechanotransduction. 
Specific Aim 3: To define the role of TRPV4 signaling in the surgical destabilization of the 
medial meniscus (DMM) model of OA. Our goals were (a) to validate a cartilage-specific, 
inducible TRPV4 knockout mouse model suitable for studying the role of TRPV4-mediated 
signaling in mature articular cartilage, and (b) to determine the effects of adult loss of 
chondrocyte TRPV4-mediated signaling on OA development and progression in the setting 
of joint destabilization.  
CHAPTER 2. TRPV4-MEDIATED CHONDROCYTE 
MECHANOTRANSDUCTION2 
 
 
 
2.1  INTRODUCTION 
Articular cartilage is the dense connective tissue that lines the surfaces of diarthrodial 
joints and provides a low friction surface for joint loading and articulation. The extracellular 
matrix (ECM) of articular cartilage is primarily comprised of proteoglycans and type II 
collagen, in addition to a sparse population of chondrocytes responsible for synthesizing and 
maintaining this tissue. The mechanical environment of articular cartilage plays an important 
role in regulating the development and maintenance of the tissue. For example, dynamic 
compressive loading of cartilage supports ECM biosynthesis [151], while abnormal loading, 
such as disuse, static loading, or altered joint biomechanics can disrupt ECM homeostasis 
[74, 152] and lead to osteoarthritis (OA) [32], a degenerative joint disease characterized by 
an imbalance of chondrocyte anabolic and catabolic activities. Most of the hypotheses on the 
etiology of OA involve biomechanical loading as a factor [32, 153]. As such, understanding 
chondrocyte mechanotransduction, i.e. how chondrocytes sense and respond to their physical 
environment is vital to understanding how OA develops and progresses, and may lead to new 
treatments for this disease.  
                                                
2 This chapter previously appeared as an article in the Proceedings of the National Academy of Sciences of the 
United States of America. The original citation is as follows:  O’Conor CJ, Leddy HA, Benefield HC, Liedtke 
WB, Guilak F. “TRPV4-mediated mechanotransduction regulates the metabolic response of chondrocytes to 
dynamic loading.” Proceedings of the National Academy of Sciences of the United States of America, 
111(4):1316-21 (2014). 
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Chondrocyte mechanotransduction appears to involve the integration and transduction 
of multiple biophysical signals that arise from joint loading, including direct matrix, cellular, 
and nuclear strain, hydrostatic pressurization, fluid shear, and changes in tissue osmolarity 
[154]. Ion channels, integrin signaling, and the primary cilia have all been implicated in 
transducing the external biophysical environment of chondrocytes into electrical and/or 
chemical intracellular signaling [60, 127, 155]. Specifically, intracellular Ca2+ signaling has 
emerged as a common regulatory mechanism for controlling gene and protein expression 
[156-158]. 
The Transient Receptor Potential Vanilloid 4 (TRPV4) channel is a multi-modally 
activated, Ca2+-preferred membrane ion channel widely implicated in transducing external 
environmental cues into specific metabolic responses via the generation of intracellular Ca2+ 
([Ca2+]i) transients [45, 159]. Human TRPV4 mutations that alter channel function are known 
to disrupt normal skeletal development and joint health [45, 61-63], and similarly, targeted 
deletion of TRPV4 in mice leads to loss of chondrocyte osmo-mechanotransduction and 
subsequently, severe joint degeneration [64]. TRPV4-mediated Ca2+ signaling has also been 
shown to enhance chondrogenic gene expression in chondroprogenitor cell lines [22], as well 
as increase matrix synthesis in chondrocyte-based self-assembled constructs [160]. However, 
the precise role of TRPV4 in transducing and regulating chondrocyte metabolic activity in 
response to mechanical loading is unclear. 
The goal of this study was to examine the hypothesis that TRPV4 transduces dynamic 
compressive loading into signals that regulate cartilage homeostasis. We first confirmed the 
presence of TRPV4 channels in chondrocyte-laden agarose constructs that produced [Ca2+]i 
transients in response to hypo-osmotic swelling and TRPV4 agonist GSK1016790A 
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(GSK101). The TRPV4 antagonist GSK205 was used to examine the role of this channel in 
regulating the response of chondrocytes to mechanical loading, while the GSK101 and 
osmotic loading were used to evaluate the effects of TRPV4 activation in the absence of 
mechanical loading. 
 
2.2 MATERIALS AND METHODS 
Cell Culture. All cell culture was performed in standard feed media (DMEM-HG, 
10% FBS, 0.1 mM NEAA, 15 mM HEPES, 40 mg/mL ι-proline, 1x antibiotics/antimycotics, 
and fresh 50 mg/mL vitamin C) unless otherwise noted, at 37°C and 5% CO2. Media 
osmolarity was measured and adjusted as detailed below. To modulate TRPV4 channel 
activity, media was supplemented with 10 mM GSK205, a TRPV4 selective antagonist [60], 
or 1 nM GSK101 (Sigma-Aldrich, St. Louis, MO), a TRPV4 selective agonist, with controls 
receiving the same amount of vehicle (0.1-0.2% DMSO) as the experimental groups. To limit 
exposure to these TRPV4 modulators, every treatment with GSK205 and GSK101 was 
followed by a wash in fresh feed media, aspiration and a new feed of fresh media. 
Osmotic Conditioning. Media osmolarity was measured with a freezing point 
osmometer (Osmette 2007; Precision Systems, Natick, MA) and adjusted down to 300 mOsm 
by the addition of distilled water. From this stock of media, the osmolarity was adjusted 
further down to 200 mOsm by the addition of distilled water or up to 400 or 600 mOsm by 
the addition of sucrose (EMD Chemical, Gibbstown, NJ). For dynamic osmotic loading (Fig. 
S3), constructs were cultured in 400 mOsm medium in mesh Netwell™ inserts (Corning Inc., 
Corning, NY) for 3 days, after which osmotic loading was initiated. To determine the effect 
of dynamic or quasi-static osmotic loading, inserts were transferred between two wells of 
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media every 5 minutes (0.00167Hz) for 1 hour/day, immediately following which all inserts 
were returned to wells of fresh 400 mOsm media (n=7-9). This loading regime was carried 
out 5 days/week for 2 weeks. During loading, control disks were transferred between 
identical wells of 400 mOsm media, while quasi-static loaded disks (+200 static and -200 
static) were transferred between identical wells of 600 or 200 mOsm media and dynamically 
loaded disks (+200 dynamic and -200 dynamic) were transferred between wells of 400 
mOsm media and either 600 or 200 mOsm media. 
Cell Isolation and Construct Formation. Full-thickness porcine articular 
chondrocytes were enzymatically isolated from the femurs and ulnas of skeletally immature 
pigs (~30kg) as described previously [60] and frozen in freezing media (10% DMEM-HG, 
10% DMSO, 80% FBS). Thawed and pooled cell suspensions from at least five donors were 
washed once with PBS, suspended in feed media and mixed 1:1 with 4% molten type VII 
agarose (Sigma-Aldrich) to form chondrocyte-laden disks (2% agarose, 4x2.25mm, 10-20M 
cells/mL). All constructs were allowed three days to equilibrate before the start of each study 
(Day 0). Media was changed for five consecutive days a week, except for the constructs used 
for Ca2+ imaging and during pre-culture periods, in which media was changed every 2-3 
days. 
Calcium Imaging. [Ca+2]i was measured in the chondrocyte-laden agarose constructs 
within the first week of culture. [Ca+2]i was measured by fluorescence ratio imaging of Fura 
Red and Fluo-3 using laser scanning microscopy at 37°C [60]. Constructs with a starting 
osmolarity of 200 mOsm were allowed to equilibrate for at least 1 hour before imaging, 
while constructs with a starting osmolality of 600 mOsm were allowed to equilibrate over 
night to facilitate proper dye loading. [Ca2+]i levels were measured by the intensity ratio of 
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the Ca2+ indicator dyes, and a positive signal was defined as an increase in the [Ca2+]i that 
was >3 SDs over the average response to control. The number of peaks in signaling cells was 
also measured using a custom written Matlab program (MathWorks, Natick, MA). 
Custom Loading Bioreactor. Dynamic compressive loading was performed as 
previously described (Figure 2.1) [161]. Briefly, a closed-loop displacement controlled 
bioreactor with 24 individual polyacetal pistons connected to a linear stage driven by a 
stepper motor was used to deliver a 10% peak-to-peak sinusoidal strain (7% offset) at 1Hz 
for 3 hours/day. Unloaded control constructs were handled and cultured alongside loaded 
constructs. 
 
Figure 2.1: Photograph of the custom loading bioreactor. A closed-loop computer 
controlled system controlling a linear motor to apply precise dynamic compressive loads to 
agarose constructs. 
 
Real time polymerase chain reaction (RT-PCR). At Day 0 and Day 14 constructs 
intended for gene expression analysis were changed to their experimental media conditions 
and incubated statically or mechanically loaded for three hours. After 24 or 72 hours, whole 
constructs were quickly rinsed with PBS and stored in RNALater (Qiagen, Valencia, CA) at -
80°C. RNA was isolated using the RNeasy Microarray Mini Kit (Qiagen). Briefly, constructs 
were blotted dry, snap frozen in Qiazol and homogenized with a bead beater, followed by 
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chloroform extraction and clean up on RNeasy Mini columns. Following RNA quantification 
(ND-1000, Fisher Scientific, Waltham, MA), cDNA was synthesized (Superscript VILO 
Express Supermix, Life Technologies, Carlsbad, CA), and amplification was performed with 
a OneStepPlus real-time PCR system, using intron spanning primers and Power SYBR 
Reaction Mix (Life Technologies). Primer sequences were designed using PrimerBlast 
(NCBI) (Table 1). Relative expression levels were quantified using the delta delta Ct method 
and normalized to 18S. 
Biochemical Assays. Constructs intended for biochemical analysis were digested in a 
125 µg/mL papain solution (Sigma-Aldrich), 100 mM phosphate buffer, 10 mM cysteine, 
and 10 mM EDTA, pH 6.3) for 16 h at 65°C. The temperature was raised to 70°C for 10 
minutes to melt the agarose, followed by vortexing. Total sulfated glycosaminoglycan (s-
GAG) content was quantified with the dimethylmethylene blue assay [162], using bovine 
chondroitin sulfate as the standard. Total collagen content was quantified using the 
orthohydroxyproline assay [163], using 0.134 as the ratio of orthohydroxyproline to collagen. 
Total DNA content was quantified using the PicoGreen fluorescent double-stranded DNA 
assay (Life Technologies). 
Histology and Immunohistochemistry. Constructs were fixed overnight at 4°C in 
phosphate-buffered formalin, dehydrated in a graded series of ethanol, cleared with xylenes, 
and embedded in paraffin. 8µm sections were cleared and rehydrated and stained with 
Safranin-O. For collagen type II immunohistochemistry, cleared and rehydrated paraffin 
sections were incubated for 5 minute in Digest-ALL 3 pepsin digestion (Life Technologies), 
treated with peroxidase, blocked with 10% goat serum, incubated with primary antibody for 
1 hr at room temperature (U of Iowa III-II6B3s), incubated with secondary antibody 
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(ab97021), treated with HRP streptavidin and AEC Red Single (Histostain-Plus BS: Life 
Technologies), counterstained with hemotoxylin, and mounted with Clearmount (Life 
Technologies). Sections from porcine osteochondral plugs were used as positive controls to 
confirm staining specificity. 
Mechanical Testing. Mechanical testing was performed in unconfined compression 
using the Enduratec ELF system (Bose, Framingham, MA) at room temperature in PBS. 
Disks were equilibrated in creep (~0.01N tare load for 300s) and then compressed at 1 µm/s 
to 10% stress, at which point the strain was held and disks were allowed to stress relax to 
equilibrium (1200s). The equilibrium force was determined by the average force over the last 
10 seconds, and the equilibrium compressive Young’s modulus (EY) was calculated by 
normalizing this equilibrium force to the original disk cross-sectional area (measured by 
digital calipers) and dividing this by the strain. The dynamic moduli were obtained by 
superimposing a 2% peak-to-peak sinusoidal displacement strain on the 10% strain at 
frequencies of 0.1, 0.5 and 1.0Hz, with five cycles imposed at each frequency. The dynamic 
moduli (G*) were determined by dividing the average amplitude of the resulting stress wave 
by the applied strain. 
Statistical Analysis. Data were analyzed using multiple-factor ANOVA, followed by 
a Fisher’s post-hoc test when appropriate. Nominal data were compared between treatment 
groups using the chi-square test. 
 
2.3 RESULTS 
TRPV4 Channel Function in Agarose-Embedded Chondrocytes. 
Immunofluorescence staining for TRPV4 revealed the presence of TRPV4 in the cellular 
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membrane of chondrocytes three days after casting in agarose (Figure 2.2A). Using 
fluorescence ratio imaging, Ca2+ concentrations in individual agarose-embedded 
chondrocytes were measured in response to increases or decreases in osmolarity and TRPV4 
activation. A significant increase in Ca2+ signaling was observed with both hypo-osmotic 
treatments (400→200 mOsm and 600→400 mOsm, p<0.001 and p<0.01 respectively), as 
well as GSK101 treatment (p<0.001), as compared to their respective iso-osmotic controls 
(Figure 2.2B,C), while the percentage of cells exhibiting a [Ca2+]i signal was the same 
between the two iso-osmotic controls (400→400 mOsm and 600→600 mOsm) (Figure 
2.2D). GSK101 produced higher percent cell signaling than 600→400 mOsm (p=0.04), but 
not the 400→200 mOsm group (p=0.58); the 400→200 mOsm group was also not different 
from the 600→400 mOsm group (p=0.15). While both hypo-osmotic and GSK101 treatments 
caused more cells to signal, GSK101 treatment generated more [Ca2+]i transients in signaling 
cells than the two hypo-osmotic treatments (Figure 2.2E, p<0.05). Pre-incubation with the 
TRPV4 inhibitor GSK205 inhibited the effect of hypotonic loading (600→400 mOsm and 
400→200 mOsm), as well as that of GSK101 treatment, and returned the percent of cells 
signaling back to control levels (400→200 mOsm+GSK205 vs 400→400 mOsm: p=0.08; 
600→400 mOsm+GSK205 vs 600→600 mOsm: p=0.49; GSK101+GSK205 vs 400→400 
mOsm: p=0.29). Neither hyper-osmotic loading condition tested (200→400 mOsm, 
400→600 mOsm) significantly affected the percentage of cells signaling as compared to the 
400→400 mOsm control, indicating that TRPV4 activation is specific to hypo-osmotic 
loading, and that signaling occurs in response to relative, and not absolute changes in 
external osmolarity. 
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Figure 2.2: TRPV4 function in agarose-embedded chondrocytes. (A) Positive labeling of 
TRPV4 in agarose-embedded chondrocytes (i) and no labeling in the no primary control (ii), 
scale bar=10µm. (B) Confocal images of a chondrocyte signaling in response to GSK101 
(arrow), indicated by the increased ratio of green:red fluorescence post-GSK101 incubation, 
scale bar=15µm. (C) Representative Ca2+ traces for conditions that demonstrate significant 
[Ca2+]i signaling as compared to the iso-osmotic control. (D) Percentage of cells responding 
to the below osmotic and chemical conditions. Data not sharing a common superscript letter 
indicate a significant difference (p<0.05). Bars do not have error bars because the percent 
responding metric does not have an error associated with it. Numbers inside the bars are the 
total of number of cells in each group. (E) Average number of peaks elicited by a signaling 
cell during the imaging period. * p<0.05 vs other groups, n=5-6, mean ± SEM. 
 
TRPV4 Inhibition During Dynamic Loading Inhibits Mechanically-Regulated 
Gene Expression. Chondrocyte-laden constructs were cultured for two weeks prior to the 
loading to allow a neo-pericellular matrix to form (Figure 2.3A,B), which an important 
structure for the transduction of mechanical signals [6, 153, 164].  
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Figure 2.3: Loading without pre-culture. Without pre-culture, and the associated elaboration 
of a pericellular matrix, mechanical loading suppresses matrix and enhances catabolic gene 
expression.   (A) s-GAG content increases dramatically with pre-culture of the chondrocyte-
laden agarose constructs. (B) Safranin-O staining shows pericellular localization of 
proteoglycans. (C-H) Gene-expression in 3-day pre-cultured (Day 0) chondrocyte-laden 
agarose constructs 24hrs and 72hrs following mechanical loading. Mechanical loading 
suppressed ACAN (C) and COL2α1 (D) gene expression 72hrs following loading, and 
enhanced (E) NOS2 and (F) ADAMTS5 gene expression 24hrs and 72hrs following loading, 
while not affecting (G) SOX9 or (H) TGF-β3 gene expression. Data not sharing a common 
superscript letter indicate a significant difference (p<0.05), * greater than Control (p<0.05), 
n=3-4, mean ± SEM. Scale bar = 2mm. 
 
Constructs were dynamically loaded for three hours, both in the presence and absence 
of GSK205, following which the media was changed and constructs collected for RNA 
extraction 24 hours and 72 hours later. Transient GSK205 exposure alone had no effect on 
gene expression levels (Figure 2.4). ACAN gene expression was not significantly affected by 
loading (24hrs: p=0.34; 72hrs: p=0.25), nor was COL2α1 (24hrs: p=0.84; 72hrs: p=0.60). 
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However, 72hrs later loading+GSK205 caused a decrease in COL2α1 (p<0.01) and an 
increase in NOS2 (p=0.02) gene expression compared to control, an effect that was not 
present with loading alone. In addition, ADAMTS5 expression was decreased with loading 
72hrs after loading (p<0.001) and this effect was partially attenuated by GSK205 (Loaded vs 
Loaded+GSK205: p<0.01). Loading and GSK205 treatment had no effect on SOX9 gene 
expression, however TGF-β3 expression was significantly increased at 24hr (p<0.01) with 
loading and this effect was fully blocked by GSK205 (Control vs Loaded+GSK205: p=0.78). 
This effect was also transient, as TGF-β3 expression in the loaded group returned to control 
levels by 72hrs. The anabolic and anti-inflammatory effect of mechanical loading on 
chondrocyte gene expression was also dependent on the two-week pre-culture period; when 
chondrocyte-laden constructs were loaded on Day 0 (three days after casting), ACAN and 
COL2α1 gene expression was suppressed and inflammatory genes ADAMTS5 and NOS2 
were highly upregulated (Figure 2.3C-H).  
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Figure 2.4: Gene expression with pre-culture. TRPV4-dependent gene-expression in two-
week pre-cultured chondrocyte-laden agarose constructs 24hrs and 72hrs after mechanical 
loading. Mechanical loading enhanced TGF-β3 (F) and suppressed ADAMTS5 gene 
expression (D) in a TRPV4-dependant manner. Inhibition of TRPV4 during mechanical 
loading also enhanced NOS2 (C) and suppressed COL2α1 (B) gene expression. * greater 
than all other groups (p<0.05), # smaller than all other groups (p<0.05), ** less than Control 
and GSK205, greater than Loaded+GSK205 (p<0.05), n=4-6, mean ± SEM. 
TRPV4 Inhibition During Dynamic Loading Inhibits Mechanically-Regulated 
Enhancement of Matrix Accumulation and Functional Properties. To determine if the 
enhancement of construct biochemical and functional properties in response to dynamic 
loading was also TRPV4-dependent, pre-cultured constructs underwent daily dynamic 
compressive loading for four weeks (3 hours/day, 5 days/week), in the presence or absence of 
GSK205. Daily transient exposure to GSK205 had no effect on construct wet weight, 
biochemical content or functional properties after four weeks of culture (Figure 2.5A). 
Dynamic loading significantly increased matrix accumulation as evidenced by the wet weight 
of the constructs (p<0.001). Furthermore, inhibition of TRPV4 with GSK205 attenuated this 
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response (Figure 2.5A). Loaded disks also exhibited an increase in both total sulfated 
glycosaminoglycan (s-GAG) content (p=0.01) and total collagen content (p<0.01), while the 
presence of GSK205 prevented these increases (Figure 2.5C,D). Loaded disks also exhibited 
an increased dynamic modulus over free-swelling controls (p=0.02), while loaded disks 
exposed to GSK205 had a significantly lower dynamic modulus than all other groups (Figure 
2.5F). In addition, although dynamic loading did not significantly affect the equilibrium 
Young’s modulus of the constructs, the addition of GSK205 during loading significantly 
decreased this property (Figure 2.4E, p<0.001). 
 
Figure 2.5: TRPV4-mediated biosynthesis with dynamic loading. TRPV4 antagonist 
GSK205 blocks the biosynthetic response of chondrocyte-laden constructs to dynamic 
mechanical loading. (A) Wet weight (B) DNA content (C) total s-GAG (D) total collagen (E) 
Young’s modulus and (F) dynamic modulus of constructs following four weeks of 
mechanical loading. * greater than all other groups (p<0.05), ** greater than GSK205 
(p<0.05), *** smaller than all other groups (p<0.05), n=3-4, mean ± SEM. 
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Direct Activation of TRPV4 Potently Drives Gene Expression, Biochemical, and 
Functional Changes Analogous To Dynamic Loading. To measure the direct effects of 
TRPV4 channel activation on chondrocyte gene expression, chondrocyte-laden constructs 
were transiently exposed to TRPV4 agonist GSK1016790A (GSK101). Similar to the effects 
of dynamic loading, NOS2 (p<0.05) and ADAMTS5 (p<0.01) gene expression were reduced 
72hrs after treatment with GSK101 (Figure 2.6). TGF-β3 gene expression was elevated 24hrs 
post-treatment (p<0.001), while GSK101 had no effect on ACAN (24hrs: p=0.61; 72hrs: 
p=0.18) and SOX9 gene expression (24hrs: p=0.50; 72hrs: p=0.94). COL2α1 (72hrs) gene 
expression was also enhanced with GSK101 treatment (p=0.001).  
 
Figure 2.6: TRPV4-dependent gene expression. Gene expression in two-week pre-cultured 
chondrocyte-laden agarose constructs 24hrs and 72hrs following TRPV4 agonist GSK101 
treatment. GSK101 enhanced (B) COL2α1 and (F) TGF-β3 and decreased (C) NOS2 (D) and 
ADAMTS5 gene expression. * greater than control (p<0.05), n=4-6, mean ± SEM. 
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In addition to direct activation of TRPV4 using GSK101, we also examined the 
effects of osmotic loading as an alternative approach for activating TRPV4 and enhancing 
ECM production. We compared four different osmotic loading regimes and found that after 
two weeks, both a +200 mOsm and -200 mOsm quasi-static stimulus enhanced total s-GAG 
accumulation (Figure 2.7).  
 
Figure 2.7: Two weeks of daily dynamic and quasi-static osmotic loading. Across all 
regimes, daily osmotic loading did not affect total DNA content (B) (p=0.415) or total 
collagen content (C) after two weeks. Hyper- and hypotonic quasi-static loading, as well as 
dynamic hypotonic loading, increased total s-GAG content (C) compared to the control 
constructs, while only quasi-static hypotonic significantly increased s-GAG/DNA (D). Data 
not sharing a common superscript letter indicate a significant difference (p<0.05), n=8-9, 
mean ± SEM. 
 
We next compared this directly to four weeks of daily GSK101 treatment, where we 
found GSK101 to be a more potent stimulus of matrix accumulation and functional property 
enhancement (Figure 2.8). At both d14 and d28, daily GSK101 treatment caused an increase 
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in wet weight and DNA per disk, as well as total s-GAG and collagen accumulation. When 
normalized to DNA content, s-GAG/DNA increased significantly with GSK101 treatment 
(p=0.001), as did collagen/DNA (p=0.05). Agonist treatment also enhanced both the Young’s 
(p=0.02) and dynamic modulus (p<0.001). Histologic staining for s-GAG and type II 
collagen further indicated an enhanced accumulation of both ECM components with 
GSK101 (Figure 2.9). 
 
Figure 2.8: TRPV4 activation enhances matrix synthesis. TRPV4 activation enhances 
extracellular matrix accumulation. (A) Wet weight (B) DNA content (C) total s-GAG (D) s-
GAG/DNA (E) total collagen (F) total collagen/DNA (G) Young’s Modulus and (H) 
Dynamic Modulus of constructs following two and four weeks of stimulation. Data not 
sharing a common superscript letter indicate a significant difference (p<0.05), n=6-8, mean ± 
SEM. 
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Figure 2.9: TRPV4 activation enhances matrix accumulation and distribution. Gross 
morphology, Safranin-O, and Collagen type II IHC after four weeks of culture, scale bar = 
2mm. 
 
 
 
2.4 DISCUSSION 
 Our results confirm the hypothesis that TRPV4 channel activation plays a critical role 
in the mechanoregulation of chondrocyte physiology and matrix metabolism in response to 
dynamic compressive loading. This study revealed a TRPV4-dependent response of 
chondrocytes to mechanical stimulation, involving transcriptional induction of anabolic 
growth factor gene expression and inhibition of pro-inflammatory mediators. This response 
was functionally validated in long-term culture, where inhibition of TRPV4 prevented 
mechanically-induced chondrocyte ECM biosynthesis and matrix accumulation. The role of 
TRPV4 channel activation on chondrocyte physiology was further confirmed using direct 
chemical activation of TRPV4, which produced a similarly potent anabolic response as 
mechanical loading. 
A compelling aspect of these findings is that they provide a specific transduction 
mechanism for an important but incompletely understood response of chondrocytes to 
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mechanical loading that has been observed in a large number of previous studies. For 
example, compressive dynamic loading typically does not confer an anabolic response in 
chondrocyte-laden constructs for at least two weeks [165], while the postponement of 
compressive loading for this same period of time is explicitly beneficial [27, 166]. Moreover, 
while compressive loading of intact cartilage explants can stimulate proteoglycan synthesis 
immediately [151, 167], the response of chondrocytes embedded in agarose is enhanced with 
additional weeks of pre-culture [168]. Cell-matrix interactions in the pericellular region are 
believed to play a critical role in transducing mechanical signals [169-171]. Several studies 
have highlighted the association of pre-culture with accumulation of a proteoglycan-rich 
pericellular matrix [6, 27, 164, 172], which can contribute to strain shielding of the 
chondrocytes [6, 164] as well as the conversion of mechanical loading to changes in 
interstitial osmolarity [106, 173]. The results of the present study not only reproduced this 
dependence of the anabolic effect of mechanical loading on pre-culture, but also suggest 
specific mechanisms involving the conversion of mechanical to osmotic stress, as well as the 
transduction of osmotic stress to an intracellular response via TRPV4 channel activation. 
Ca2+ signaling elicited by hypo-osmotic stress or GSK101 in our model system of 
chondrocyte-laden agarose constructs was attenuated back to control levels by GSK205, 
confirming that these responses were transduced via TRPV4. [Ca2+]i transients were elicited 
by hypo-osmotic challenge independent of base osmolarity, whereas iso-osmotic and hyper-
osmotic loading had no effect on [Ca2+]i signaling. These findings suggest that osmotically-
mediated activation of TRPV4 in chondrocytes is in response to relative, and not absolute, 
hypo-osmotic stress. Thus, while cells may not signal in response to the hyper-osmotic 
conditions of compression, they may be activated by relative hypo-osmolarity when 
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compression is removed. In addition, GSK101 elicited significantly more [Ca2+]i transients 
during the imaging period than the hypo-osmotic loading conditions (600→400 and 
400→200mOsm), an indication that pharmacologic targeting of TRPV4 may provide a more 
potent method of activating TRPV4 than a single hypo-osmotic stimulus of physiologic 
magnitude.  
[Ca2+]i signaling is believed to be one of the earliest events in the response of 
chondrocytes to mechanical stimulation [112, 174, 175]. Previous studies have observed 
[Ca2+]i signaling in response to mechanical loading [176, 177]; interestingly, these studies 
detected [Ca2+]i signaling in chondrocyte-laden constructs without substantial pre-culture 
(<72hrs), although chondrocytes synthesize small amounts of pericellular proteoglycans even 
within 2 days of culture in agarose [169] that could contribute to mechanically-induced 
[Ca2+]i signaling. Thus, the effects of loading with and without pre-culture, observed in this 
study as well as in previous studies, may be due differences in the characteristics of the 
[Ca2+]i signal with pre-culture, or perhaps other environmental and cellular factors that 
change over time [165, 168, 169, 178]. Though chondrocyte [Ca2+]i signaling exhibits a high 
sensitivity to variations in osmolarity or volume [17, 18, 179, 180], there is little or no 
sensitivity to physiologic levels of other physical stimuli, such as direct membrane stretch, 
suggesting that membrane connections to the pericellular matrix and/or intracellular 
cytoskeleton are important for the generation and transduction of [Ca2+]i transients. TRPV4 
has known physical interactions with both transmembrane proteins (integrins) [181, 182] and 
cytoskeletal elements (microtubules, actin, tubulin) [46, 183], and can transduce a diverse set 
of environmental signals [184]. However, the complete mechanism of TRPV4 channel 
activation during chondrocyte loading remains to be determined. 
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We observed transcriptional control of ADAMTS5, NOS2, COL2α1, and TGF-β3 in 
response to mechanical loading or GSK101-mediated TRPV4 channel activation.  
Furthermore, inhibition of TRPV4 during loading prevented mechanoregulation of these 
genes. ADAMTS5 is a previously identified mechanoresponsive gene in loaded chondrocyte 
constructs [27] and has also been implicated in mechanically-induced models of 
osteoarthritis [185]. Interestingly, disruption of primary cilia, a structure also required for 
TRPV4-mediated transduction of osmotic swelling [60], has been shown to increase 
ADAMTS5 gene expression [186]. Mechanical loading of chondrocytes in agarose can reduce 
nitric oxide production [187], and our results suggest that mechanical activation of TRPV4 
contributes to the suppression of NOS2 expression. GSK101 enhanced COL2α1 expression, 
and although COL2a1 did not increase with loading, inhibiting TRPV4 during loading did 
reduce its expression. Thus, TRPV4-mediated Ca2+ appears to support ECM gene expression, 
particularly under dynamic mechanical loading. TRPV4-mediated enhancement of COL2α1 
gene expression has also been observed in the ATDC5 cell line [22]. However, unlike the 
response of ATDC5 chondroprogenitors, we did not concurrently observe transcriptional 
enhancement of chondrocyte SOX9 with TRPV4 activation, suggesting that fully 
differentiated articular chondrocytes utilize an alternate mechanism for COL2α1 
enhancement. Transforming growth factor (TGF) signaling plays an important role in 
cartilage development and homeostasis [188], as well as the response of other cell types to 
mechanical stimulation [189, 190]. The mechanoresponsiveness of chondrocyte TGF-β3 
gene expression that preceded the regulation of the other genes measured in this study, along 
with its dependence on TRPV4 activity to mediate this response, represents an intriguing 
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potential mechanism for the biophysical to biochemical transduction of mechanical loading 
in articular cartilage.  
Inhibition of TRPV4 with GSK205 blocked the compositional and functional 
enhancement of mechanically-loaded chondrocyte-laden constructs, further supporting the 
role of TRPV4-mediated mechanotransduction in regulating chondrocyte matrix metabolism. 
Functional testing of the mechanically loaded constructs revealed that the mechanically 
loaded disks with GSK205 had functional properties below that of the unloaded controls. 
Blocking TRPV4 during loading may have allowed for mechanical fatigue of the agarose in 
the setting of inhibited ECM production (e.g., a decrease in COL2α1 expression) or perhaps 
increased catabolic or disrupted matrix organization processes (e.g., an increase in NOS2 and 
ADAMTS5 expression). GSK101 treatment also produced increases in construct matrix 
accumulation and functional properties, which again could be due to both increased 
production and/or suppressed catabolism and matrix organization. Future transcriptome-wide 
analyses [191, 192] may be useful in identifying the pathways that drive these loading-
induced changes.  
Activation of TRPV4 with GSK101 potently enhanced matrix accumulation and 
functional properties of the chondrocyte-agarose constructs, even in the absence of a pre-
culture period. In addition, matrix deposition in GSK101-treated constructs appeared more 
uniform throughout the construct depth than in the control and osmotically-treated groups 
(Figure 2.9). In this regard, the use of a small molecule chemical agonist to accelerate tissue 
formation may have significant advantages over the use of growth factors or direct 
mechanical stimulation in a bioreactor, particularly for large anatomically-shaped tissue 
grafts [193], where diffusion limitations or an inhomogenous mechanical environment may 
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lead to nonuniform tissue deposition.  It will also be important to determine if targeting 
TRPV4 can also enhance the chondrogenesis and maturation of human stem cell-based tissue 
engineered cartilage. 
In summary, the findings from this study demonstrate that TRPV4 activation is a key 
mechanism of mechanical signal transduction in articular chondrocytes. This finding further 
highlights the ability of mechanotransduction pathways to have profound effects on cellular 
physiology and function, as well as the ability of ion channel modulators to control these 
functions.  Further understanding of this process may provide insights into the development 
of new therapies for cartilage repair or osteoarthritis, as well as other diseases related to 
aberrant mechanotransduction [194].  
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CHAPTER 3. TRPV4 IN OBESITY-ASSOCIATED OSTEOARTHRITIS3 
 
 
 
3.1 INTRODUCTION 
Obesity is one of the most significant and modifiable risk factors for osteoarthritis 
(OA) [195]. However, local biomechanical factors associated with changes in the onset and 
progression of knee OA in the obese population [35, 196] cannot explain the relationship 
between obesity and OA in non-load bearing joints [197]. Obesity and related metabolic 
syndromes are associated with chronic low-grade inflammation and systemic tissue damage 
[198]. There is further evidence to suggest that these systemic metabolic factors participate in 
the development of OA in both weight bearing and non-weight bearing joints [138]; 
however, the mechanisms by which these systemic factors alter the course of OA remain 
unclear [199].  
The transient receptor potential vanilloid 4 (TRPV4) ion channel is a Ca2+-preferred 
cation channel, originally characterized as a transducer of osmotic stress [43, 44]. TRPV4-
mediated Ca2+ signaling in response to osmotic fluctuations in the cartilage is one potential 
mechanism by which chondrocytes sense and respond to joint loading [60]. TRPV4 signaling 
plays a crucial role in skeletal development [200, 201]. Furthermore, genetically-encoded 
deletion of TRPV4 in mice leads to accelerated joint degeneration with aging [64]. 
                                                
3 This chapter previously appeared as an article in the Annals of Rheumatic Diseases. The original citation is as 
follows: O’Conor CJ, Griffin TM, Liedtke W, Guilak F. “Increased susceptibility of Trpv4-deficient mice to 
obesity and obesity-induced osteoarthritis with very high-fat diet.” Annals of Rheumatic Diseases, 72(2):300-4 
(2013). 
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Interestingly, chondrocyte TRPV4 is also known to interact with pro-inflammatory mediators 
and cytokines to mediate catabolic signaling and nociception [202, 203]. 
We hypothesized that the absence of TRPV4-mediated signaling in the presence of 
the catabolic, biomechanical and inflammatory factors of obesity would accelerate OA 
progression in the high-fat diet model of OA. To examine the link between the observed 
phenotype of Trpv4−/− mice and function of TRPV4 at the cellular level, we measured the 
effects of TRPV4 deficiency on the intrinsic capabilities of bone marrow-derived stem cells 
(MSCs) and adipose-derived stem cells (ASCs), isolated from Trpv4−/− and Trpv4+/+ mice, to 
differentiate towards the adipogenic, osteogenic, and chondrogenic lineages. 
 
3.2 MATERIALS AND METHODS 
Animal handling. All animal care and experimental procedures were conducted 
under a protocol approved by the Duke University Institutional Animal Care and Use 
Committee. 10 week old male pan-Trpv4 knockout (Trpv4-/-) mice and wild-type C57BL/6 
(Trpv4+/+) mice were placed on either a high-fat diet (60% kcal; #12492) or control diet 
(10% kcal; #12540B) (Research Diets, Inc., New Brunswick, NJ) (n=36). Animals were 
maintained on their respective diets for 22 weeks, during which time, spontaneous 
locomotor activity was measured by an automated photobeam apparatus, with light-phase 
and dark-phase locomotor activity collected with the VersaMax program (Omnitech 
Digiscan, AccuScan Instruments, Inc., Columbus, OH) [138]. 
Body composition. Immediately following sacrifice, total body fat of each mouse 
was measured using Dual Energy X-ray absorptiometry (DXA, PIXImus, Lunar Corp, 
Madison, WI), with the head excluded from analysis [138]. 
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Histological evaluation of OA. After DXA scanning, hind limbs were formalin 
fixed and paraffin embedded. 6µm coronal sections of the knee joint were stained with 
Hematoxylin, Safranin-O and Fast Green. Sections from the tibiofemoral cartilage-cartilage 
contact region in the medial and lateral condyles were scored for degenerative changes 
using a modified Mankin system by three blinded graders, evaluating for cartilage structural 
damage, proteoglycan loss, tidemark duplication, subchondral bone thickening, 
fibrocartilage, chondrocyte hypertrophy, and chondrocyte cloning [204]. Average scores 
were tabulated for each of the four compartments of the joint and combined to one total 
joint score. Subcutaneous fat tissue from 10-week old Trpv4-/- and Trpv4+/+ mice was also 
fixed, paraffin embedded, and 6µm sections were stained with Hematoxylin and Eosin. 
Stem cell isolation, purification and expansion. Bone marrow derived stem cells 
(MSC) and subcutaneous adipose-derived stem cells (ASC) were isolated from the femurs 
and tibias (MSC isolation), and the inguinal fat pad (ASC isolation) of 3-5 Trpv4-/- and 
Trpv4+/+ mice (8-10 weeks old), using a previously described method involving 
fluorescence-activated cell sorting (FACS) to obtain cells with specific cell markers (MSC: 
CD45-/TER-119-/Sca-1+/PDGFRα+; ASC: CD45-/TER-119-/CD31-/Sca-1+/CD34+), and 
expanded to P3 as described in [205, 206]. 
Tridifferentiation. At passage 3, MSCs and ASCs were induced toward 
differentiation towards the adipogenic, osteogenic, or chondrogenic lineages [206]. For 
adipogenesis, cells were plated at 10,000/cm2 on standard tissue culture plastic for three 
days in adipogenic control media (DMEM/F12 (Lonza, Walkersville, MD), 10% FBS and 
1% penicillin/streptomycin/fungizone (P/S/F, Invitrogen, Carlsbad, CA)), at which time, 
experimental wells were changed to adipogenic control media plus adipogenic factors 
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(33µM biotin, 17µM pantothenate, 1µM bovine insulin, 1µM dexamethasone (all from 
Sigma-Aldrich, St. Louis, MO)), with the addition of 250µM isobutylmethylxanthine 
(IBMX) and 2µM rosiglitazone (Avandia™, GlaxoSmithKline, Middlesex, UK) for the first 
three days only)). Adipogenic potential was assayed by Oil-Red-O stain release. For 
osteogenesis, cells were plated at 10,000/cm2 on standard tissue culture plastic for three 
days in osteogenic control media (DMEM-HG (Invitrogen), 10% FBS and 1% P/S/F), at 
which time, experimental wells were changed to osteogenic control media plus osteogenic 
factors (10mM b-glycerophosphate (Sigma), 250µM ascorbate-2-phosphate (Sigma), 2.5µM 
retinoic acid (Sigma), and 50ng/mL hBMP-2 (R&D systems, Minneapolis, MN)). 
Osteogenic potential was assayed by Alizarin stain release. For chondrogenic 
differentiation, 250,000 MSCs and ASCs were pelleted in 15mL polypropylene tubes by 
centrifugation at 300g for 5 minutes. Cells were fed a chondrogenic control medium of 
DMEM-HG (Invitrogen), 1% ITS+ (BD biosciences, San Jose, CA), 50 µg ascorbate-2-
phosphate (Sigma), 40 µg/mL proline (Sigma), with ASC pellet media being supplemented 
with 10% FBS. On day three, experimental pellets were changed to chondrogenic control 
media plus 10ng/mL human transforming growth factor-_3 (hTGF-b3) and 500ng/mL 
human bone morphogenetic protein-6 (hBMP-6, R&D). After 28 days, pellets were 
processed for Alcian Blue/Nuclear Fast Red staining or biochemical analysis for double 
stranded DNA with the PicoGreen assay and glycosaminoglycan content with the 1,9 
dimethylmethylene blue (DMB) assay. 
Statistical analysis. Normality was tested, and data were log-transformed before 
analysis if necessary. Statistical analysis was performed using multiple-factor analysis of 
variance for comparison of multiple groups, with Fisher Least Significant Difference (LSD) 
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post-hoc analysis using α=0.05. Significant differences were reported at the 95% CI unless 
otherwise noted. Data are presented as mean±SEM. 
 
3.3 RESULTS 
Trpv4−/− mice are more susceptible to diet-induced obesity than Trpv4+/+ mice. 
Trpv4−/− mice weighed significantly more than Trpv4+/+ mice at 10 weeks of age (Figure 
3.1A,B). After being fed a high-fat diet, Trpv4−/− mice gained significantly more weight than 
Trpv4+/+ mice (Figure3.1A,B). DXA measurements after high-fat feeding revealed that the 
differences in body mass with genotype and diet were due to body fat, with Trpv4−/− mice 
gaining significantly more body fat than Trpv4+/+ mice following high-fat feeding (Figure 
3.1C). To further examine the obese phenotype of Trpv4−/− mice, histological sections were 
taken of the inguinal fat pad of 10-week-old normally fed mice and showed that even prior to 
high-fat feeding, Trpv4−/− mice may possess larger adipocytes than Trpv4+/+ controls (Figure 
3.1D). 
High-fat fed Trpv4−/− mice have lower cage activity than high-fat fed Trpv4+/+ 
mice. To further investigate the relationship between Trpv4 deficiency and increased weight 
gain, spontaneous cage activity was measured after 3 days of habituation. For mice fed a 
control fat diet, genotype had no effect on dark cycle locomotor activity (p=0.332); yet, 
when fed a high-fat diet, Trpv4−/− mice were 40% as active as Trpv4+/+ mice (Figure 3.1E). 
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Figure 3.1: Trpv4-/- mice exhibit increased adiposity in response to high-fat feeding. (A) 
High-fat fed mice weighed significantly more than control diet mice by Week 7. By Week 
10, KO 60% mice weigh significantly more than all other groups. (B) WT 60% mice gained 
(insignificantly) more weight after 32 weeks compared to WT 10% mice (p=0.0837), 
whereas KO 60% mice gained more weight than all other groups. (C) Post-diet, mice did not 
differ in the amount of lean body mass. WT 60% mice had significantly more body fat than 
WT 10% mice, but KO 60% had the more body fat than all other groups. (D) Histological 
sections of subcutaneous adipose tissue from 10 week old mice, where KO adipocytes appear 
larger than WT adipocytes, Scale bar = 100 µm. Data are shown as mean ± SEM. & Trpv4 
KO > WT (p<0.05), * 60% diet > 10% diet (p<0.05), ^ 60% KO > all other groups (p<0.05), 
+ 60% KO > 10% WT (p<0.05). Data not sharing a common superscript letter indicate a 
significant difference (p<0.05). 
 
Trpv4 deficiency increases knee OA following high-fat feeding. A modified 
Mankin score was tabulated and analyzed that combined the score for cartilage structural 
degeneration and proteoglycan loss as recommended in reference. Neither Trpv4−/− nor 
high-fat feeding alone increased joint degeneration; however, the combination of the two 
factors increased OA severity (Figure3.2 A,B). Trpv4−/− mice also demonstrated altered 
chondrocyte histomorphology, with reduced chondrocyte cloning and chondrocyte 
hypertrophy (Figure3.2C). 
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Figure 3.2. Trpv4-/- mice have more severe diet-induced osteoarthritis and altered 
chondrocyte histomorphology. (A) Representative histological images, scale bar = 500 µm. 
(B) KO 60% mice have more severe joint degeneration than WT 10% mice (p=0.05). (C) 
Trpv4-/- joints have less chondrocyte cloning and chondrocyte hypertrophy. Data are shown 
as mean ± SEM. Data not sharing a common superscript letter indicate a significant 
difference (p<0.05). 
 
Altered in vitro differentiation of Trpv4−/− progenitor cells. MSCs and ASCs 
were isolated from 10-week-old Trpv4−/− and Trpv4+/+ mice and expanded to P3. No effect 
of genotype on expansion rate was observed (Figure 3.3A1). Trpv4−/− MSCs exhibited a 
reduced adipogenic differentiation potential compared to MSCs isolated from Trpv4+/+ 
mice, whereas Trpv4−/− ASCs demonstrated a largely increased adipogenic differentiation 
potential compared to Trpv4+/+ ASCs (Figure 3.3A2,B). Similarly, Trpv4−/− MSCs 
demonstrated a reduced osteogenic differentiation potential while Trpv4−/− ASCs had an 
increased osteogenic differentiation potential (Figure3.3A,C). No effect of Trpv4 deficiency 
was observed with MSC chondrogenic differentiation. However, Trpv4−/− ASCs 
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demonstrated a reduced chondrogenic differentiation potential compared to Trpv4+/+ ASCs, 
as indicated by less GAG/DNA (Figure 3.3D) and Alcian blue staining (Figure 3.3A4). 
 
Figure 3.3: Adult stem cells from Trpv4-/- mice exhibit altered differentiation 
potential. Data for adipogensis and osteogenesis were normalized to DNA content and to the 
staining of cells cultured in control media. (A) 1. MSCs and ASC from Trpv4-/- mice 
expanded equally rapidly in hypoxic culture. (A2-4) A: WT MSC B: WT ASC C: KO MSC 
D: KO ASC. (A2) Cell morphology at day 7 of adipogenic differentiation. (A3) Alizarin 
Red staining at day 14 osteogenesis. (A,4) Chondrogenically induced cell pellets (Alcian 
Blue/Nuclear Fast Red). (B) Bone marrow derived MSCs have a reduced ability to 
differentiate when cultured in adipogenic media, while ASCs show a large increase. (C) 
Bone marrow derived MSCs have a reduced ability to differentiate when cultured in 
osteogenic media, while ASCs show an increased ability. (D) Trpv4 deficiency does not 
affect in vitro MSC chondrogenesis. However, Trpv4-/- ASCs have decreased GAG 
accumulation and Alcian Blue staining. Data are shown as mean ± SEM. * indicates 
significant difference (p<0.05). 
  
 
3.4 DISCUSSION 
Our findings indicate that TRPV4 exhibits a chondroprotective role in diet-induced 
OA. Trpv4−/− mice exhibited an increased susceptibility to high fat diet-induced OA, 
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potentially due in part to an increased susceptibility to diet-induced obesity. MSCs and ASCs 
from these mice also demonstrated altered differentiation potential, with ASCs from Trpv4−/− 
mice exhibiting significantly higher adipogenic potential and decreased chondrogenic 
potential. 
Our observations that very high-fat fed Trpv4−/− mice are particularly prone to 
obesity stands in contrast with the findings by Kusudo et al [207] that pan-Trpv4−/− mice are 
protected from diet-induced obesity. However, substantial differences exist between these 
two studies, including age at diet initiation, composition, and duration of high-fat feeding. In 
this study, mice were fed a 60% high-fat diet for 22 weeks, beginning at 10 weeks, compared 
to a 42% kcal diet beginning at 16 weeks and lasting 12 weeks.[207] In addition, although we 
did not measure food consumption or energy expenditure in our study (no effect of Trpv4 
knockout was found by Kusudo et al[207]), we observed reduced cage activity of high-fat 
fed Trpv4−/− mice. It is unclear, however, whether this represents a cause and/or a 
consequence of the additional weight gain of Trpv4−/− mice. Additionally, given the 
chondroprotective effect of activity in the setting of diet-induced obesity [140], it is even 
possible that this decrease in activity increased the severity of joint degeneration in the 
Trpv4−/− mice directly. 
While neither high-fat feeding nor Trpv4 deficiency alone increased OA severity at 8 
months of age, a combination of these two factors did. This finding is generally consistent 
with previous work showing that Trpv4−/− mice exhibit significant spontaneous OA changes 
at 9 months [64]. Similarly, high-fat diet feeding alone did not produce a significant increase 
in OA, but is consistent with previous similarly designed studies. Though this study supports 
the hypothesis that TRPV4 plays a role in the pathogenesis of obesity-associated OA, further 
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investigation is needed to fully describe the cartilage-specific role of TRPV4 in obesity and 
OA. 
Trpv4−/− mice at 52 weeks of age exhibited a chondrocyte morphology that is distinct 
from that of Trpv4+/+ mice, with less chondrocyte cloning and hypertrophy observed in the 
articular cartilage of Trpv4−/− mice. The cause of chondrocyte cloning (or chondrocyte 
cluster formation) in osteoarthritic cartilage and its influence on cartilage disease progression 
is unknown, but may signify a proliferative repair response [208] Chondrocyte hypertrophy 
in articular cartilage also signifies altered metabolic activity by chondrocytes following tissue 
damage and inflammation [209, 210]. Further studies will be needed to determine if TRPV4 
mediates these or other chondrocyte responses to joint insult. 
We observed an altered metabolic and osteoarthritic response of Trpv4−/− mice to 
high-fat feeding. In an attempt to better understand the role of this channel in these 
mesodermally-derived tissues, we examined whether adult stem cells would also exhibit 
altered growth or differentiation characteristics in vitro that reflect the tissue characteristics 
observed in vivo. Isolated MSCs from Trpv4−/− mice exhibited reduced adipogenesis, while 
ASCs revealed significantly increased adipogenesis. Consistent with these in vitro findings, 
adipocytes in Trpv4−/− mice appeared larger than those of Trpv4+/+ mice at 10 weeks of age. 
Determining the role of TRPV4 in adipose tissue function, as is being actively pursued with 
other TRP channels [211], could yield important insight into both metabolic and 
inflammatory-associated diseases. 
The role of TRPV4 in bone metabolism is also evident in Trpv4−/− mice, which 
display increased bone volume that may in fact contribute to increased cartilage degeneration 
directly [64]. While the skeletal phenotype of Trpv4−/− mice has been largely attributed to 
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impaired osteoclast function [48], we found that Trpv4−/− MSCs exhibited reduced 
osteogenesis, while Trpv4−/− ASCs exhibited increased osteogenesis. Future investigations 
are needed to fully deconstruct the role of TRPV4 in bone development, remodeling and 
repair. 
Though we found no effect of TRPV4 in MSC chondrogenesis, it is plausible that the 
potent application of growth factors required to induce in vitro chondrogenesis (TGF-β3, 
BMP-6) may have overpowered the effect of basal TRPV4 signaling in these cells. TRPV4 
activation in chondroprogenitors has been shown to enhance Sox9 expression in a Ca2+-
dependent manner, one of the main regulators of cartilage-specific expression of matrix 
molecules such as collagen type II and aggrecan [22]. Interestingly, we observed that 
chondrogenesis was diminished in Trpv4−/− ASCs, possibly due to the altered phenotype and 
metabolism of the pan-Trpv4−/− adipose tissue, rather than indicating a direct effect of loss of 
TRPV4 signaling with chondrogenic differentiation. Further studies are necessary to 
establish the role of TRPV4 in adipose tissue that led to the pro-obesity phenotype in our 
Trpv4−/− mice. 
This study demonstrates that global loss of Trpv4 increases knee OA severity in 
response to high-fat feeding in a manner that is associated with increased weight gain. 
However, the effects of pan-Trpv4 deletion, such as alterations in bone remodeling [48, 64] 
and energy metabolism, complicates conclusions regarding the in vivo role of various 
progenitor cells in this model system. There may be other systemic effects of pan-Trpv4 
knockout as well, including altered nociception, given the involvement of TRPV4 in joint 
inflammation and pain [203, 212] Use of tissue-targeted Cre-lox systems [147, 213, 214] will 
help to define the tissue-specific effects of TRPV4 signaling with respect to obesity, joint 
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inflammation, pain and OA. Determining the cartilage-specific role of TRPV4 in the many 
etiologies and models of OA, including obesity-induced OA, should provide new insight into 
molecular mechanisms that link biomechanical and inflammatory factors of OA, hopefully 
leading to new preventions and treatments for this prevalent disease. 
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CHAPTER 4. THE ROLE OF TRPV4 IN A MODEL OF INSTABILITY-INDUCED 
OSTEOARTHRITIS 
 
 
 
4.1 INTRODUCTION  
Osteoarthritis (OA) is a common cause of pain and disability, affecting over 27 
million people in the United States [7]. Major risk factors for OA include age, obesity, and 
prior joint injury [32]. Non-surgical treatments can provide a degree of symptomatic relief, 
but ultimately do not address the underlying disease process. Understanding the biological 
and environmental factors that influence disease progression is critical to developing 
therapies to slow or prevent OA pathogenesis [153]. 
During OA progression, an imbalance of anabolic and catabolic activities by resident 
articular chondrocytes promotes tissue degradation [33, 34, 215]. This loss of homeostatic 
balance can be heavily influenced by biomechanical factors, particularly in the setting of 
altered joint kinematics [32]. A better understanding of the biophysical and molecular signal 
transduction pathways involved in regulating articular cartilage homeostasis is needed, 
particularly in the setting of mechanically-influenced OA pathogenesis. 
Animal models of OA that recapitulate clinically relevant mechanisms of OA disease 
onset and progression include aging [216], diet-induced obesity [199], and joint 
destabilization [217]. Destabilization of the medial meniscus (DMM), via transection of the 
medial meniscotibial ligament, alters joint biomechanics in mice and causes pathologic 
changes similar to those seen in human post-traumatic OA following ACL or meniscal tears 
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[217]. Inducible and tissue-specific transgenic animal models further provide the ability to 
determine the role of specific genes and pathways during disease progression in a temporal 
and tissue-targeted fashion [218].  
The TRPV4 ion channel transduces mechanical loading in articular cartilage via the 
generation of mechanically-induced intracellular Ca2+ transients. Global deletion of Trpv4 
accelerates OA progress in aging and obesity models of OA [64, 219]. However, the precise 
role of chondrocyte mechanotransduction in influencing OA disease development and 
progression remains unclear. The investigation presented here uses an inducible, cartilage-
specific Trpv4 knockout mouse model to determine the role of TRPV4-mediated cartilage 
mechanotransduction during destabilization-induced osteoarthritis. 12 weeks following 
destabilization, persistent synovitis was found in destabilized joints of cKO mice, while 
synovitis in the destabilized joint of the WT mice resolved to within the levels of the 
contralateral limb. However, overall OA progression, measured by cartilage degeneration 
and pathological bone changes, was not affected loss of chondrocyte TRPV4 signaling. 
These results suggest a role of chondrocyte TRPV4 in resolving joint inflammation following 
destabilization, although loss of TRPV4-mediated cartilage mechanotransduction was not 
sufficient to exacerbate destabilization-induced cartilage degeneration and OA progression. 
 
4.2 MATERIAL AND METHODS 
Generation of transgenic mice. All procedures were performed in accordance with 
an Institutional Animal Care and Use Committee-approved protocol. Col2a1-CreERT2 mice 
were generously provided by Dr. Di Chen [220], and crossed with Trpv4lox/lox transgenic mice 
(used to generate epidermal-specific Trpv4 null mice [159]). Male Col2a1-
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CreERT2+;Trpv4lox/lox  (cKO) and Col2a1-CreERT2-/-;Trpv4lox/lox  (WT) littermates were 
induced with tamoxifen (Sigma, 1 mg/10 g body weight, IP, daily for 3 days) at 10 weeks of 
age.  Mice for immunohistochemistry and functional Ca2+ imaging were sacrificed two 
weeks following induction. 
Immunostaining. For immunostaining, cKO and WT mouse knees were fixed in 4% 
paraformaldehyde overnight and cryosectioned (8 µm thick). Slides were blocked with 10% 
goat serum, incubated with the TRPV4 antibody (1:1000, ACC-034, Alomone, Jerusalem, 
Israel), followed by the Alexa Fluor 633 conjugated secondary (1:1000, A-21070, Life 
Technologies, Carlsbad, CA). 
Calcium Imaging. Chondrocyte TRPV4 channel function was evaluated by in situ 
fluorescence ratio imaging of Ca2+ indicator dyes using previously described methods [64]. 
Briefly, freshly-dissected medial femoral condyles of WT and cKO mice were imaged on a 
confocal microscope, and intracellular Ca2+ signaling was evaluated in response TRPV4 
agonist GSK101 (Sigma, 2 nM) and hypo-osmotic stress (-100 mOsm). 
DMM Destabilization. Two weeks following tamoxifen administration, 3-month-old 
cKO and WT mice underwent destabilization of their left knee via transection of the 
medialmeniscotibial ligament as described previously [217]. Briefly, mice were induced 
under anesthesia via isofluorane induction and an incision was made on the anteriomedial 
knee. The patellar ligament was transected to visualize the medial meniscus and its anterior 
insertion was transected. The joint capsule was sutured closed and tissue adhesive was 
applied to close the skin. 
microCT. Immediately following sacrifice, hind limbs were formalin-fixed and 
scanned (Skyscan 1176 MicroCT, Bruker, Billerica, MA). The following parameters were 
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used for reconstruction: Dynamic range 0.0975 to 0.1025, Beam Hardening 40, Ring Artifact 
6. A post-alignment parameter was set specifically for each image.  Reconstructed images 
were oriented so that the tibial growth plate was horizontally positioned.  If the femoral 
growth plate was later found to be at a suboptimal angle, the reconstructed images were 
separately reoriented for femoral analysis. 
The following parameters were evaluated: Total joint bone volume (TJBV; a measure 
of all bone volume between the femoral and tibial growth plate, excluding calcified menisci), 
subchondral bone thickness (SCBT; calculated as the mean of three measurements taken 
from a sagittal section in the middle of each joint region), bone mineral density (BMD), and 
bone volume (BV). SCBT, BMD and BV were calculated separately for four joint regions: 
the medial and lateral femoral condyles (MFC & LFC) and medial and lateral tibial plateaus 
(MTP & LTP). BMD and BV were calculated for the trabecular regions of each region, 
delineated proximally by the first subchondral axial slice with trabecular bone to one slice 
prior to the growth plate.  
Histology Methods. Knee joints were then decalcified (Cal-Ex Decalcification 
Solution; Fisher Scientific), dehydrated, embedded in paraffin via an automated tissue 
processor (ASP300S; Leica Microsystems) and sectioned by microtome (8 µm coronal 
slices). Sections were stained with Hematoxylin, Fast Green, and Safranin-O for modified 
Mankin and osteophyte scoring, or Hematoxyin and Eosin for synovitis grading. Digital 
micrographs were taken of the slides and the scores from three blinded graders were 
averaged. 
Statistical Analysis. Nominal data (Ca2+ signaling) were compared between 
treatment groups using the chi-square test (p<0.05). TJBV and SCT comparisons were 
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conducted using two-way ANOVA with Tukey’s post-hoc pairwise tests. BV and BMD 
analysis and semi-quantitative histologic scoring (not normally distributed) was conducted 
using non-parametric Kruskal-Wallis ANOVA with post-hoc Wilcoxon Rank Sum test for 
pairwise comparisons (p<0.05). 
 
4.3 RESULTS 
Confirmation of TRPV4 knockout. Immunofluorescence staining confirmed loss of 
TRPV4 in the articular cartilage of cKO mice two week after induction, with TRPV4 staining 
persistent in the subchondral bone (Figure 4.1). WT chondrocytes responded significantly to 
hypo-osmotic and GSK101 treatment with an ~2x increase in the percentage of chondrocytes 
exhibiting a Ca2+ signal. Chondrocytes from cKO mice two week after induction 
demonstrated no response to these stimuli, indicating a functional loss of TRPV4-mediated 
Ca2+ signaling. 
 
Figure 4.1: Cartilage-specific TRPV4 knockout. Immunohistochemical staining and 
functional calcium imaging confirming tissue specific and functional loss of TRPV4 in the 
articular cartilage two weeks after induciton with tamoxifen. 
 
Effects of cartilage-specific TRPV4 KO on behavior and body morphology. cKO 
mice did not demonstrate any perceivable differences in feeding, behavior, or gait as 
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compared to WT mice. No differences were observed between cKO and WT body weight, 
bone mineral density, and bone mineral content, both before and after DMM. A higher body 
fat percentage was found in cKO at 4.5 months of age (1.5 months after DMM), though this 
effect was transient, with no significance between groups 1.5 months later.  
 
Figure 4.2: TRPV4 cKO produces little changes in body composition. Body weight, total 
body fat percent, and total body bone mineral density at 0, 1.5, and 3 months following 
tamoxifen induction. 
 
Effects of cartilage-specific TRPV4 KO on DMM-induced histologic changes. By 
semi-quantitative histological measures, cKO and WT mice demonstrated an equivalent 
susceptibility to destabilization-induced osteoarthritic degeneration. Contralateral, 
unoperated limbs from both mouse strains had a similarly mild degree of degenerative 
changes, and DMM surgery in both mouse strains caused a significant increase of 
osteoarthritic disease in the operated knee, characterized by mild-to-moderate loss of 
proteoglycan staining, cartilage erosion, and subchondral sclerosis. Total joint synovitis 12 
weeks after surgery was significantly increased on the operated joint of cKO mice 
(p=0.0141), while the effect of DMM on synovitis in the WT mice, as compared to the 
contralateral control limb, was not significant. 
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Figure 4.3: Osteoarthritis progression and synovial inflammation in TRPV4 cKO mice 
following DMM. Loss of chondrocyte TRPV4 did not alter osteoarthritis progression 
following DMM, although cKO mice had residual synovitis 3 months following DMM that 
was not observed in WT mice. 
 
Effects of cartilage-specific TRPV4 KO on total joint and subchondral bone. 
Neither surgery no loss of TRPV4 had an effect on total joint bone volume, nor was an effect 
found on bone mineral density or bone volume, when analyze both by individual quadrant as 
well as the total joint. Subchondral bone thickness increased with DMM surgery in the 
medial femoral condyle only, with no effect of TRPV4 knockout. 
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Figure 4.4: Bone changes with microCT analysis. Total joint bone volume was not affected 
by DMM or TRPV4 knockout. DMM increased medial femoral condyle subchondral bone 
thickness, but no effect of TRPV4 knockout was found. 
 
4.4 DISCUSSION 
The pathways involved in mechanically-induced cartilage degeneration and OA are of 
interest as potential therapeutic target for preventing post-traumatic OA development and 
progression [153]. Cartilage-specific, inducible transgenic animal models are powerful tools 
for testing the role of specific pathways of interest during OA disease pathogenesis. In this 
study, we evaluated the effect of TRPV4-mediated cartilage mechanotransduction during 
destabilization-induced OA, using an adult-induced, cartilage-specific TRPV4 knockout 
mouse. As measured by osteoarthritis scoring, osteophyte formation, and subchondral bone 
changes, we found that loss of TRPV4 signaling does not alter OA disease progression or 
severity, though TRPV4 signaling appears to play a role in resolving destabilization-induced 
synovitis. 
 Some of the earliest changes of mechanically-induced OA include chondrocyte 
apoptosis and pericellular proteoglycan loss, which suggests an involvement of chondrocyte 
mechanobiology in 
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compressive loading into an anabolic/anti-catabolic response that supports cartilage 
extracellular matrix accumulation and tissue properties [221]. However, the role of this ion 
channel in transducing injurious regimes of mechanical loading is less well understood. 
While loss of the channel did not alter the histologic course of OA progression in our 
analysis, the increased persistence of synovitis of cKO mice indicates that TRPV4 may still 
play a measureable role in the response of chondrocytes to joint destabilization. Specifically, 
TRPV4 may have a role modulating the response to joint destabilization and altered joint 
biomechanics, but is overwhelmed by other biophysical or chemical signaling pathways. 
Given the entire channelome expressed by chondrocytes [110], there also may be other ion 
channels that play a more predominate role in transducing destabilized-joint loading patterns. 
This study examined the role of TRPV4 specifically in articular cartilage, due to the 
dominant role of this tissue in osteoarthritis. However, the presence of TRPV4 in other peri-
articular tissues, such as synovium [222] and bone [223], together with the channels known 
multi-modal activation mechanisms, also leaves open the possibility of non-chondrocyte 
TRPV4 effects during OA pathogenesis. 
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CHAPTER 5. DISCUSSION 
 
 
 
5.1 TECHNIQUES AND FUTURE DIRECTIONS 
The goal of this dissertation was to understand the role of TRPV4-mediated Ca2+ 
signaling on the function and articular cartilage under both physiologic and pathologic 
mechanical loading. Found within is a description of TRPV4-mediated cartilage 
mechanobiology that is both mechanistic as well as disease-oriented. The power of the 
findings can be attributed in large part to the concurrent application of methodologies from 
individual disciplines, including tissue engineering and tissue biomechanics, ion channel 
pharmacology and physiology, osteoarthritis pathology and modeling, and mouse genetic 
engineering, into single experiments. 
 In vitro techniques. The model culture system predominately adopted in this work, 
chondrocyte-seeded agarose, has been widely used previously to examine the response of 
chondrocytes to mechanical stimulation [165]. This dissertation built upon the general body 
of knowledge that mechanical loading stimulates chondrocyte biosynthesis by detailing the 
effects of one particular transduction mechanism, TRPV4-mediated mechanotransduction. 
Specifically, the use of channel-specific modulators and cell, gene, and protein level 
experiments have generated a robust, though clearly not-yet complete, working model of 
cartilage mechanotransduction. The complete nature of the study has clearly defined the role 
of chondrocyte TRPV4 in sensing relative, and not absolute, hypo-osmotic, but not hypo-
osmotic, changes, which is highly relevant to the dynamic nature of cartilage tissue loading.  
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Importantly, this cell-agarose system is not without its own limitations. This system 
was carried out using a mixed pool of full thickness chondrocytes that underwent enzymatic 
isolation to reproduce a significant, but incomplete peri- and extracellular matrix. In addition, 
the mechanical and biochemical incongruities of the agarose environment to the cartilage in 
situ environment call for future experimentation on the role of TRPV4 in intact cartilage 
loading. Human and other large mammalian articular cartilage possesses distinct zones (deep, 
middle, superficial) that have unique cell populations, as well as distinct matrix compositions 
and properties. The generation of unique biophysical signals, and hence, different mechanical 
transduction mechanism within each particular zone of human cartilage would not be 
surprising. Identifying particular pathologic or therapeutic zones of mechanotransduction in 
cartilage would be highly valuable in developing therapies to treat human OA, but would 
have to be carried out in the appropriate species (i.e. not rodent cartilage, which largely lack 
this zonal organization). 
It also bears noting the technical and practical limitations of the type of 3D primary 
cell culture performed in this dissertation. Limited cell yields, donor variability, and typically 
low throughput assays are all factors that could make doing certain experiments, such as 
basic signaling work or channel physiology experiments, using cell lines and/or simple, 
monolayer cartilage, more appropriate, at least for initial characterization. Of the multitude of 
question that remain regarding TRPV4-mediated mechanotransduction, perhaps the most 
enticing question is the precise molecular mechanism of TRPV4 channel activation during 
mechanical loading. The mechanism(s) of TRPV4 channel gating has remained elusive, but 
appears to contain distinct mechanism for particular stimuli [224]. High-throughput, 
mutational and electrophysiological studies, as well as computational modeling, will likely 
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be initially required before the findings can be applied to understanding the molecular 
mechanisms of cartilage mechanotransduction.  
 In vivo techniques. Tissue-specific, inducible transgenic mouse models are of great 
value in revealing the role of specific genes and pathways in joint health and disease. This 
approach will likely help elucidate the role of additional ion channels and proposed 
mechanosensory pathways in articular cartilage.  
It will also be important to investigate the role of mechanotransduction in the other 
peri-articular tissues, including subchondral bone, meniscus, ligament, and synovium. It has 
been shown using nestin-Cre;TGFBR2lox mice, whose TGFβΙΙ receptor knockout is confined 
to bone marrow-resident MSCs, that TGFβ signaling in MSCs within the subchondral bone 
play an important role in destabilization-induced OA pathogenesis [225]. The development 
of analogous mice strains for tissue-specific expression in meniscus, ligament, and synovium, 
as well as perhaps nerves and blood vessels that penetrate into the articular region, would 
allow the study of a particular genes role in every tissue of the joint. 
Pain is an often-overlooked aspect of OA research that necessitates further basic in 
vitro investigation, as well as the targeted use of animal models. In this latter case, the 
approaches and resources dedicated here to in vivo ion channel research on cartilage 
mechanotransduction may ultimately translate to understanding and treating the cause of pain 
associated with OA [226]. Nociceptive afferent neurons innervate ligaments, meniscus, 
subchondral bone, and synovium, and express many similar ion channels, including TRP, 
voltage-gated calcium channels, acid-sensing channels, potassium channels, and purinergic 
channels. Importantly, however, joint inflammation both sensitizes neurons as well as leads 
to new neuron ingrowth. Thus, the development of analgesics for joint nociception, both 
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peripherally and centrally activating, in combination with therapeutic approaches to 
minimize joint inflammation and joint tissue degeneration may be necessary to block pain 
and improve patient outcomes. 
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APPENDIX A 
 
Table 1. Porcine PCR primer sequences 
Gene ID Full Gene Name Forward Reverse NCBI Reference Sequence 
18S 18S ribosomal RNA 
CGGCTACC
ACATCCA
AGGAA 
GGGCCTC
GAAAGAG
TCCTGT 
NR_046261.1 
ACAN Aggrecan 
CAGACTGT
CAGATAC
CCCATTG 
GTGTGGC
AAAGAAC
ACTTCCC 
NM_001164652.1 
COL2α1 Collagen type II, alpha 1 
CTGAAAG
ACTGCCTC
AGCCC 
TTTCTGT
CCCTTTG
GTCCCAG 
XM_001925959.5 
NOS2 Nitric oxide synthase 2, inducible 
TTTCAGGA
AGCATCA
CCCCC 
CAAAGAG
CACGGCT
TTGACC 
NM_001143690.1 
ADAMTS
5 
ADAM metallopeptidase 
with thrombospondin 
type 1 motif, 5 
ATGTGAC
ACCCTGG
GAATGG 
AGGCCAA
GCAGATG
TCCAAT 
XM_003132747.4 
SOX9 (Sex determining region Y)-box 9 
ACTCTGGA
GACTGCTG
AATGAG 
GCCGTTC
TTCACCG
ACTTCC 
NM_213843.1 
TGF-β3 Transforming growth factor, beta 3 
TGATTCCT
CCAGACC
GGCTA 
TTCATGG
ACCCACT
TCCAGC 
NM_214198.1 
 
 
 
 
 
 
 
  - 70 - 
REFERENCES 
 
1. Hunziker, E.B., T.M. Quinn, and H.J. Hauselmann, Quantitative structural 
organization of normal adult human articular cartilage. Osteoarthritis Cartilage, 2002. 
10(7): p. 564-72. 
 
2. McDevitt, C.A., Biochemistry of articular cartilage. Nature of proteoglycans and 
collagen of articular cartilage and their role in ageing and in osteoarthrosis. Ann Rheum Dis, 
1973. 32(4): p. 364-78. 
 
3. Martel-Pelletier, J., et al., Cartilage in normal and osteoarthritis conditions. Best 
Pract Res Clin Rheumatol, 2008. 22(2): p. 351-84. 
 
4. Quinn, T.M., et al., Physical and biological regulation of proteoglycan turnover 
around chondrocytes in cartilage explants. Implications for tissue degradation and repair. 
Ann N Y Acad Sci, 1999. 878: p. 420-41. 
 
5. Verzijl, N., et al., Effect of collagen turnover on the accumulation of advanced 
glycation end products. J Biol Chem, 2000. 275(50): p. 39027-31. 
 
6. Alexopoulos, L.G., L.A. Setton, and F. Guilak, The biomechanical role of the 
chondrocyte pericellular matrix in articular cartilage. Acta Biomater, 2005. 1(3): p. 317-25. 
 
7. Murphy, L. and C.G. Helmick, The impact of osteoarthritis in the United States: a 
population-health perspective. Am J Nurs, 2012. 112(3 Suppl 1): p. S13-9. 
 
8. Felson, D.T., et al., Osteoarthritis: new insights. Part 1: the disease and its risk 
factors. Ann Intern Med, 2000. 133(8): p. 635-46. 
 
9. Arden, N. and M.C. Nevitt, Osteoarthritis: epidemiology. Best Pract Res Clin 
Rheumatol, 2006. 20(1): p. 3-25. 
 
10. Racunica, T.L., et al., Effect of physical activity on articular knee joint structures in 
community-based adults. Arthritis Rheum, 2007. 57(7): p. 1261-8. 
 
11. Stove, J., et al., Metabolic activity and gene expression of osteoarthritic chondrocytes 
in correlation with radiological and histological characteristics. Biomed Pharmacother, 2006. 
60(10): p. 644-7. 
 
12. Felson, D.T., et al., Weight loss reduces the risk for symptomatic knee osteoarthritis 
in women. The Framingham Study. Ann Intern Med, 1992. 116(7): p. 535-9. 
 
13. Urban, J.P., A.C. Hall, and K.A. Gehl, Regulation of matrix synthesis rates by the 
ionic and osmotic environment of articular chondrocytes. J Cell Physiol, 1993. 154(2): p. 
262-70. 
 
  - 71 - 
14. Guilak, F. and C.T. Hung, Physical Regulation of Cartilage Metabolism2004: 
Lippincott WIlliams & Willkins. 
 
15. Elder, B.D. and K.A. Athanasiou, Hydrostatic pressure in articular cartilage tissue 
engineering: from chondrocytes to tissue regeneration. Tissue Eng Part B Rev, 2009. 15(1): 
p. 43-53. 
 
16. Chen, C., et al., Biomechanical properties and mechanobiology of the articular 
chondrocyte. Am J Physiol Cell Physiol, 2013. 305(12): p. C1202-8. 
 
17. Erickson, G.R., D.L. Northrup, and F. Guilak, Hypo-osmotic stress induces calcium-
dependent actin reorganization in articular chondrocytes. Osteoarthritis Cartilage, 2003. 
11(3): p. 187-97. 
 
18. Erickson, G.R., L.G. Alexopoulos, and F. Guilak, Hyper-osmotic stress induces 
volume change and calcium transients in chondrocytes by transmembrane, phospholipid, and 
G-protein pathways. J Biomech, 2001. 34(12): p. 1527-35. 
 
19. Chao, P.H., A.C. West, and C.T. Hung, Chondrocyte intracellular calcium, 
cytoskeletal organization, and gene expression responses to dynamic osmotic loading. Am J 
Physiol Cell Physiol, 2006. 291(4): p. C718-25. 
 
20. Hardingham, G.E. and H. Bading, Calcium as a versatile second messenger in the 
control of gene expression. Microsc Res Tech, 1999. 46(6): p. 348-55. 
 
21. Dolmetsch, R.E., et al., Differential activation of transcription factors induced by 
Ca2+ response amplitude and duration. Nature, 1997. 386(6627): p. 855-8. 
 
22. Muramatsu, S., et al., Functional gene screening system identified TRPV4 as a 
regulator of chondrogenic differentiation. J Biol Chem, 2007. 282(44): p. 32158-67. 
 
23. Wicks, S.J., et al., Inactivation of smad-transforming growth factor beta signaling by 
Ca(2+)-calmodulin-dependent protein kinase II. Mol Cell Biol, 2000. 20(21): p. 8103-11. 
 
24. Valhmu, W.B., et al., Load-controlled compression of articular cartilage induces a 
transient stimulation of aggrecan gene expression. Arch Biochem Biophys, 1998. 353(1): p. 
29-36. 
 
25. Wong, M., M. Siegrist, and X. Cao, Cyclic compression of articular cartilage explants 
is associated with progressive consolidation and altered expression pattern of extracellular 
matrix proteins. Matrix Biol, 1999. 18(4): p. 391-9. 
26. Li, Y., et al., Moderate dynamic compression inhibits pro-catabolic response of 
cartilage to mechanical injury, tumor necrosis factor-alpha and interleukin-6, but accentuates 
degradation above a strain threshold. Osteoarthritis Cartilage, 2013. 21(12): p. 1933-41. 
 
  - 72 - 
27. Jeon, J.E., et al., Effect of preculture and loading on expression of matrix molecules, 
matrix metalloproteinases, and cytokines by expanded osteoarthritic chondrocytes. Arthritis 
Rheum, 2013. 65(9): p. 2356-67. 
 
28. Fitzgerald, J.B., et al., Mechanical compression of cartilage explants induces multiple 
time-dependent gene expression patterns and involves intracellular calcium and cyclic AMP. 
J Biol Chem, 2004. 279(19): p. 19502-11. 
 
29. Lin, P.M., C.T. Chen, and P.A. Torzilli, Increased stromelysin-1 (MMP-3), 
proteoglycan degradation (3B3- and 7D4) and collagen damage in cyclically load-injured 
articular cartilage. Osteoarthritis Cartilage, 2004. 12(6): p. 485-96. 
 
30. Aigner, T., et al., Large-scale gene expression profiling reveals major pathogenetic 
pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum, 2006. 54(11): p. 3533-
44. 
 
31. Goldring, S.R., The role of bone in osteoarthritis pathogenesis. Rheum Dis Clin 
North Am, 2008. 34(3): p. 561-71. 
 
32. Guilak, F., Biomechanical factors in osteoarthritis. Best Pract Res Clin Rheumatol, 
2011. 25(6): p. 815-23. 
 
33. Sandell, L.J. and T. Aigner, Articular cartilage and changes in arthritis. An 
introduction: cell biology of osteoarthritis. Arthritis Res, 2001. 3(2): p. 107-13. 
 
34. Sandell, L.J., Anabolic factors in degenerative joint disease. Curr Drug Targets, 2007. 
8(2): p. 359-65. 
 
35. Felson, D.T., et al., Obesity and knee osteoarthritis. The Framingham Study. Ann 
Intern Med, 1988. 109(1): p. 18-24. 
 
36. Houard, X., M.B. Goldring, and F. Berenbaum, Homeostatic mechanisms in articular 
cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep, 2013. 15(11): p. 
375. 
 
37. Lohmander, L.S., et al., The long-term consequence of anterior cruciate ligament and 
meniscus injuries: osteoarthritis. Am J Sports Med, 2007. 35(10): p. 1756-69. 
 
38. Tang, Z., et al., Coordinated expression of MMPs and TIMPs in rat knee intra-
articular tissues after ACL injury. Connect Tissue Res, 2009. 50(5): p. 315-22. 
 
39. Wei, T., et al., Analysis of early changes in the articular cartilage transcriptisome in 
the rat meniscal tear model of osteoarthritis: pathway comparisons with the rat anterior 
cruciate transection model and with human osteoarthritic cartilage. Osteoarthritis Cartilage, 
2010. 18(7): p. 992-1000. 
 
  - 73 - 
40. Englund, M., et al., Meniscus pathology, osteoarthritis and the treatment controversy. 
Nat Rev Rheumatol, 2012. 8(7): p. 412-9. 
 
41. Li, R.T., et al., Predictors of radiographic knee osteoarthritis after anterior cruciate 
ligament reconstruction. Am J Sports Med, 2011. 39(12): p. 2595-603. 
 
42. Nilius, B. and V. Flockerzi, Mammalian transient receptor potential (TRP) cation 
channels. Handbook of Expiermental Pharmacology. Vol. Volume 1. 2014, New York: 
Heidelberg. 
 
43. Liedtke, W., et al., Vanilloid receptor-related osmotically activated channel (VR-
OAC), a candidate vertebrate osmoreceptor. Cell, 2000. 103(3): p. 525-35. 
 
44. Strotmann, R., et al., OTRPC4, a nonselective cation channel that confers sensitivity 
to extracellular osmolarity. Nat Cell Biol, 2000. 2(10): p. 695-702. 
 
45. Everaerts, W., B. Nilius, and G. Owsianik, The vanilloid transient receptor potential 
channel TRPV4: from structure to disease. Prog Biophys Mol Biol, 2010. 103(1): p. 2-17. 
 
46. Suzuki, M., A. Hirao, and A. Mizuno, Microtubule-associated [corrected] protein 7 
increases the membrane expression of transient receptor potential vanilloid 4 (TRPV4). J 
Biol Chem, 2003. 278(51): p. 51448-53. 
 
47. Becker, D., J. Bereiter-Hahn, and M. Jendrach, Functional interaction of the cation 
channel transient receptor potential vanilloid 4 (TRPV4) and actin in volume regulation. Eur 
J Cell Biol, 2009. 88(3): p. 141-52. 
 
48. Masuyama, R., et al., TRPV4-mediated calcium influx regulates terminal 
differentiation of osteoclasts. Cell Metab, 2008. 8(3): p. 257-65. 
 
49. Alessandri-Haber, N., et al., Hypotonicity induces TRPV4-mediated nociception in 
rat. Neuron, 2003. 39(3): p. 497-511. 
 
50. Alessandri-Haber, N., et al., TRPV4 mediates pain-related behavior induced by mild 
hypertonic stimuli in the presence of inflammatory mediator. Pain, 2005. 118(1-2): p. 70-9. 
 
51. Chung, M.K., H. Lee, and M.J. Caterina, Warm temperatures activate TRPV4 in 
mouse 308 keratinocytes. J Biol Chem, 2003. 278(34): p. 32037-46. 
 
52. Fernandez-Fernandez, J.M., et al., Maxi K+ channel mediates regulatory volume 
decrease response in a human bronchial epithelial cell line. Am J Physiol Cell Physiol, 2002. 
283(6): p. C1705-14. 
 
53. Guatteo, E., et al., Temperature sensitivity of dopaminergic neurons of the substantia 
nigra pars compacta: involvement of transient receptor potential channels. J Neurophysiol, 
2005. 94(5): p. 3069-80. 
  - 74 - 
 
54. Tian, W., et al., Renal expression of osmotically responsive cation channel TRPV4 is 
restricted to water-impermeant nephron segments. Am J Physiol Renal Physiol, 2004. 287(1): 
p. F17-24. 
 
55. Lee, H. and M.J. Caterina, TRPV channels as thermosensory receptors in epithelial 
cells. Pflugers Arch, 2005. 451(1): p. 160-7. 
 
56. Liedtke, W., TRPV4 as osmosensor: a transgenic approach. Pflugers Arch, 2005. 
451(1): p. 176-80. 
 
57. Liedtke, W., TRPV4 plays an evolutionary conserved role in the transduction of 
osmotic and mechanical stimuli in live animals. J Physiol, 2005. 567(Pt 1): p. 53-8. 
 
58. Nilius, B., H. Watanabe, and J. Vriens, The TRPV4 channel: structure-function 
relationship and promiscuous gating behaviour. Pflugers Arch, 2003. 446(3): p. 298-303. 
 
59. Nilius, B. and T. Voets, Diversity of TRP channel activation. Novartis Found Symp, 
2004. 258: p. 140-9; discussion 149-59, 263-6. 
 
60. Phan, M.N., et al., Functional characterization of TRPV4 as an osmotically sensitive 
ion channel in porcine articular chondrocytes. Arthritis Rheum, 2009. 60(10): p. 3028-37. 
 
61. Lamande, S.R., et al., Mutations in TRPV4 cause an inherited arthropathy of hands 
and feet. Nat Genet, 2011. 43(11): p. 1142-6. 
 
62. Kang, S.S., et al., Human skeletal dysplasia caused by a constitutive activated 
transient receptor potential vanilloid 4 (TRPV4) cation channel mutation. Exp Mol Med, 
2012. 44(12): p. 707-22. 
 
63. Leddy, H.A., et al., Follistatin in chondrocytes: the link between TRPV4 
channelopathies and skeletal malformations. FASEB J, 2014. 
 
64. Clark, A.L., et al., Chondroprotective role of the osmotically sensitive ion channel 
transient receptor potential vanilloid 4: age- and sex-dependent progression of osteoarthritis 
in Trpv4-deficient mice. Arthritis Rheum, 2010. 62(10): p. 2973-83. 
 
65. Pittenger, M.F., et al., Multilineage potential of adult human mesenchymal stem cells. 
Science, 1999. 284(5411): p. 143-7. 
 
66. Guilak, F., et al., 2010 Nicolas Andry Award: Multipotent adult stem cells from 
adipose tissue for musculoskeletal tissue engineering. Clin Orthop Relat Res, 2010. 468(9): 
p. 2530-40. 
 
67. De Bari, C., et al., Multipotent mesenchymal stem cells from adult human synovial 
membrane. Arthritis Rheum, 2001. 44(8): p. 1928-42. 
  - 75 - 
 
68. Tae, S.K., et al., Mesenchymal stem cells for tissue engineering and regenerative 
medicine. Biomed Mater, 2006. 1(2): p. 63-71. 
 
69. Matsumoto, T., et al., Articular cartilage repair with autologous bone marrow 
mesenchymal cells. J Cell Physiol, 2010. 225(2): p. 291-5. 
 
70. Estes, B.T., et al., Isolation of adipose-derived stem cells and their induction to a 
chondrogenic phenotype. Nat Protoc, 2010. 5(7): p. 1294-311. 
 
71. Fan, J., et al., Synovium-derived mesenchymal stem cells: a new cell source for 
musculoskeletal regeneration. Tissue Eng Part B Rev, 2009. 15(1): p. 75-86. 
 
72. Guilak, F., Compression-induced changes in the shape and volume of the chondrocyte 
nucleus. J Biomech, 1995. 28(12): p. 1529-41. 
 
73. Guilak, F. and V.C. Mow, The mechanical environment of the chondrocyte: a 
biphasic finite element model of cell-matrix interactions in articular cartilage. J Biomech, 
2000. 33(12): p. 1663-73. 
 
74. Guilak, F., et al., The effects of matrix compression on proteoglycan metabolism in 
articular cartilage explants. Osteoarthritis Cartilage, 1994. 2(2): p. 91-101. 
 
75. Buschmann, M.D., et al., Chondrocytes in agarose culture synthesize a mechanically 
functional extracellular matrix. J Orthop Res, 1992. 10(6): p. 745-58. 
 
76. Lee, D.A. and D.L. Bader, The development and characterization of an in vitro 
system to study strain-induced cell deformation in isolated chondrocytes. In Vitro Cell Dev 
Biol Anim, 1995. 31(11): p. 828-35. 
 
77. Byers, B.A., et al., Transient exposure to transforming growth factor beta 3 under 
serum-free conditions enhances the biomechanical and biochemical maturation of tissue-
engineered cartilage. Tissue Eng Part A, 2008. 14(11): p. 1821-34. 
 
78. Mauck, R.L., et al., Synergistic action of growth factors and dynamic loading for 
articular cartilage tissue engineering. Tissue Eng, 2003. 9(4): p. 597-611. 
79. Freeman, P.M., et al., Chondrocyte cells respond mechanically to compressive loads. 
J Orthop Res, 1994. 12(3): p. 311-20. 
 
80. Choi, J.B., et al., Zonal changes in the three-dimensional morphology of the chondron 
under compression: the relationship among cellular, pericellular, and extracellular 
deformation in articular cartilage. J Biomech, 2007. 40(12): p. 2596-603. 
 
81. Hdud, I.M., A. Mobasheri, and P.T. Loughna, Effects of cyclic equibiaxial 
mechanical stretch on alpha-BK and TRPV4 expression in equine chondrocytes. 
Springerplus, 2014. 3: p. 59. 
  - 76 - 
 
82. de Vries, S., et al., Deformation Thresholds for Chondrocyte Death and the Protective 
Effect of the Pericellular Matrix. Tissue Eng Part A, 2014. 
 
83. Soltz, M.A. and G.A. Ateshian, Interstitial fluid pressurization during confined 
compression cyclical loading of articular cartilage. Ann Biomed Eng, 2000. 28(2): p. 150-9. 
 
 
84. Hall, A.C., J.P. Urban, and K.A. Gehl, The effects of hydrostatic pressure on matrix 
synthesis in articular cartilage. J Orthop Res, 1991. 9(1): p. 1-10. 
 
85. Mauck, R.L., et al., Regulation of cartilaginous ECM gene transcription by 
chondrocytes and MSCs in 3D culture in response to dynamic loading. Biomech Model 
Mechanobiol, 2007. 6(1-2): p. 113-25. 
 
86. Hung, C.T., et al., A paradigm for functional tissue engineering of articular cartilage 
via applied physiologic deformational loading. Ann Biomed Eng, 2004. 32(1): p. 35-49. 
 
87. Park, S., et al., Cartilage interstitial fluid load support in unconfined compression. J 
Biomech, 2003. 36(12): p. 1785-96. 
 
88. Bachrach, N.M., V.C. Mow, and F. Guilak, Incompressibility of the solid matrix of 
articular cartilage under high hydrostatic pressures. J Biomech, 1998. 31(5): p. 445-51. 
 
89. Toyoda, T., et al., Upregulation of aggrecan and type II collagen mRNA expression in 
bovine chondrocytes by the application of hydrostatic pressure. Biorheology, 2003. 40(1-3): 
p. 79-85. 
 
90. Elder, B.D. and K.A. Athanasiou, Synergistic and additive effects of hydrostatic 
pressure and growth factors on tissue formation. PLoS One, 2008. 3(6): p. e2341. 
 
91. Angele, P., et al., Cyclic hydrostatic pressure enhances the chondrogenic phenotype 
of human mesenchymal progenitor cells differentiated in vitro. J Orthop Res, 2003. 21(3): p. 
451-7. 
 
92. Miyanishi, K., et al., Effects of hydrostatic pressure and transforming growth factor-
beta 3 on adult human mesenchymal stem cell chondrogenesis in vitro. Tissue Eng, 2006. 
12(6): p. 1419-28. 
 
93. Wagner, D.R., et al., Hydrostatic pressure enhances chondrogenic differentiation of 
human bone marrow stromal cells in osteochondrogenic medium. Ann Biomed Eng, 2008. 
36(5): p. 813-20. 
 
94. Miyanishi, K., et al., Dose- and time-dependent effects of cyclic hydrostatic pressure 
on transforming growth factor-beta3-induced chondrogenesis by adult human mesenchymal 
stem cells in vitro. Tissue Eng, 2006. 12(8): p. 2253-62. 
  - 77 - 
 
95. Finger, A.R., et al., Differential effects on messenger ribonucleic acid expression by 
bone marrow-derived human mesenchymal stem cells seeded in agarose constructs due to 
ramped and steady applications of cyclic hydrostatic pressure. Tissue Eng, 2007. 13(6): p. 
1151-8. 
 
96. Puetzer, J., et al., The effects of cyclic hydrostatic pressure on chondrogenesis and 
viability of human adipose- and bone marrow-derived mesenchymal stem cells in three-
dimensional agarose constructs. Tissue Eng Part A, 2013. 19(1-2): p. 299-306. 
 
97. Li, J., et al., p38 MAPK mediated in compressive stress-induced chondrogenesis of 
rat bone marrow MSCs in 3D alginate scaffolds. J Cell Physiol, 2009. 221(3): p. 609-17. 
 
98. Li, J., et al., The influence of delayed compressive stress on TGF-beta1-induced 
chondrogenic differentiation of rat BMSCs through Smad-dependent and Smad-independent 
pathways. Biomaterials, 2012. 33(33): p. 8395-405. 
 
99. Hopewell, B. and J.P. Urban, Adaptation of articular chondrocytes to changes in 
osmolality. Biorheology, 2003. 40(1-3): p. 73-7. 
 
100. Negoro, K., et al., Effect of osmolarity on glycosaminoglycan production and cell 
metabolism of articular chondrocyte under three-dimensional culture system. Clin Exp 
Rheumatol, 2008. 26(4): p. 534-41. 
 
101. Xu, X., et al., Osmolarity effects on bovine articular chondrocytes during three-
dimensional culture in alginate beads. Osteoarthritis Cartilage, 2010. 18(3): p. 433-9. 
 
102. Oswald, E.S., et al., Effects of hypertonic (NaCl) two-dimensional and three-
dimensional culture conditions on the properties of cartilage tissue engineered from an 
expanded mature bovine chondrocyte source. Tissue Eng Part C Methods, 2011. 17(11): p. 
1041-9. 
 
103. Tew, S.R., et al., Hyperosmolarity regulates SOX9 mRNA posttranscriptionally in 
human articular chondrocytes. Am J Physiol Cell Physiol, 2009. 297(4): p. C898-906. 
 
104. Peffers, M.J., et al., Regulation of SOX9 in normal and osteoarthritic equine articular 
chondrocytes by hyperosmotic loading. Osteoarthritis Cartilage, 2010. 18(11): p. 1502-8. 
 
105. Coleman, J.L., et al., Diurnal variations in articular cartilage thickness and strain in 
the human knee. J Biomech, 2012. 
 
106. Oswald, E.S., et al., Dependence of zonal chondrocyte water transport properties on 
osmotic environment. Cell Mol Bioeng, 2008. 1(4): p. 339-348. 
 
107. Wuertz, K., et al., Behavior of mesenchymal stem cells in the chemical 
microenvironment of the intervertebral disc. Spine (Phila Pa 1976), 2008. 33(17): p. 1843-9. 
  - 78 - 
 
108. Liang, C., et al., Responses of human adipose-derived mesenchymal stem cells to 
chemical microenvironment of the intervertebral disc. J Transl Med, 2012. 10: p. 49. 
 
109. Caron, M.M., et al., Osmolarity determines the in vitro chondrogenic differentiation 
capacity of progenitor cells via nuclear factor of activated T-cells 5. Bone, 2013. 53(1): p. 
94-102. 
 
110. Barrett-Jolley, R., et al., The emerging chondrocyte channelome. Front Physiol, 2010. 
1: p. 135. 
 
111. Browning, J.A., et al., The influence and interactions of hydrostatic and osmotic 
pressures on the intracellular milieu of chondrocytes. Biorheology, 2004. 41(3-4): p. 299-
308. 
 
112. Han, S.K., et al., Mechanically induced calcium signaling in chondrocytes in situ. J 
Orthop Res, 2012. 30(3): p. 475-81. 
 
113. Pingguan-Murphy, B., et al., Cyclic compression of chondrocytes modulates a 
purinergic calcium signalling pathway in a strain rate- and frequency-dependent manner. J 
Cell Physiol, 2006. 209(2): p. 389-97. 
 
114. Fitzgerald, J.B., M. Jin, and A.J. Grodzinsky, Shear and compression differentially 
regulate clusters of functionally related temporal transcription patterns in cartilage tissue. J 
Biol Chem, 2006. 281(34): p. 24095-103. 
 
115. Mouw, J.K., S.M. Imler, and M.E. Levenston, Ion-channel regulation of chondrocyte 
matrix synthesis in 3D culture under static and dynamic compression. Biomech Model 
Mechanobiol, 2007. 6(1-2): p. 33-41. 
 
116. Natoli, R.M., et al., Intracellular Na(+) and Ca(2+) modulation increases the tensile 
properties of developing engineered articular cartilage. Arthritis Rheum, 2010. 62(4): p. 
1097-107. 
 
117. Blain, E.J., Involvement of the cytoskeletal elements in articular cartilage 
homeostasis and pathology. Int J Exp Pathol, 2009. 90(1): p. 1-15. 
 
118. Trickey, W.R., T.P. Vail, and F. Guilak, The role of the cytoskeleton in the 
viscoelastic properties of human articular chondrocytes. J Orthop Res, 2004. 22(1): p. 131-9. 
 
119. Knight, M.M., et al., Mechanical compression and hydrostatic pressure induce 
reversible changes in actin cytoskeletal organisation in chondrocytes in agarose. J Biomech, 
2006. 39(8): p. 1547-51. 
 
120. Giannoni, P., et al., The mechanosensitivity of cartilage oligomeric matrix protein 
(COMP). Biorheology, 2003. 40(1-3): p. 101-9. 
  - 79 - 
 
121. Chowdhury, T.T., et al., Integrin-mediated mechanotransduction in IL-1 beta 
stimulated chondrocytes. Biomech Model Mechanobiol, 2006. 5(2-3): p. 192-201. 
 
122. Wang, J.H. and B.P. Thampatty, An introductory review of cell mechanobiology. 
Biomech Model Mechanobiol, 2006. 5(1): p. 1-16. 
 
123. Hoey, D.A., M.E. Downs, and C.R. Jacobs, The mechanics of the primary cilium: an 
intricate structure with complex function. J Biomech, 2012. 45(1): p. 17-26. 
 
124. Wilsman, N.J., Cilia of adult canine articular chondrocytes. J Ultrastruct Res, 1978. 
64(3): p. 270-81. 
 
125. Poole, C.A., M.H. Flint, and B.W. Beaumont, Analysis of the morphology and 
function of primary cilia in connective tissues: a cellular cybernetic probe? Cell Motil, 1985. 
5(3): p. 175-93. 
 
126. Whitfield, J.F., The solitary (primary) cilium--a mechanosensory toggle switch in 
bone and cartilage cells. Cell Signal, 2008. 20(6): p. 1019-24. 
 
127. Muhammad, H., et al., The primary cilium as a dual sensor of mechanochemical 
signals in chondrocytes. Cell Mol Life Sci, 2012. 69(13): p. 2101-7. 
 
128. McGlashan, S.R., C.G. Jensen, and C.A. Poole, Localization of extracellular matrix 
receptors on the chondrocyte primary cilium. J Histochem Cytochem, 2006. 54(9): p. 1005-
14. 
 
129. Wann, A.K., et al., Primary cilia mediate mechanotransduction through control of 
ATP-induced Ca2+ signaling in compressed chondrocytes. FASEB J, 2012. 26(4): p. 1663-
71. 
 
130. Martins, R.P., et al., Mechanical regulation of nuclear structure and function. Annu 
Rev Biomed Eng, 2012. 14: p. 431-55. 
 
131. Lee, D.A., et al., Chondrocyte deformation within compressed agarose constructs at 
the cellular and sub-cellular levels. J Biomech, 2000. 33(1): p. 81-95. 
 
132. Finan, J.D., et al., Nonlinear osmotic properties of the cell nucleus. Ann Biomed Eng, 
2009. 37(3): p. 477-91. 
 
133. Finan, J.D. and F. Guilak, The effects of osmotic stress on the structure and function 
of the cell nucleus. J Cell Biochem, 2010. 109(3): p. 460-7. 
 
134. Wang, X.D., et al., Sustained inflammation induces degeneration of the 
temporomandibular joint. J Dent Res, 2012. 91(5): p. 499-505. 
 
  - 80 - 
135. Lewis, J.S., et al., Acute joint pathology and synovial inflammation is associated with 
increased intra-articular fracture severity in the mouse knee. Osteoarthritis Cartilage, 2011. 
19(7): p. 864-73. 
 
136. Leong, D.J., et al., Matrix metalloproteinase-3 in articular cartilage is upregulated by 
joint immobilization and suppressed by passive joint motion. Matrix Biol, 2010. 29(5): p. 
420-6. 
 
137. Nam, J., et al., Transcriptome-wide gene regulation by gentle treadmill walking 
during the progression of monoiodoacetate-induced arthritis. Arthritis Rheum, 2011. 63(6): p. 
1613-25. 
 
138. Griffin, T.M., et al., Diet-induced obesity differentially regulates behavioral, 
biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res Ther, 2010. 
12(4): p. R130. 
 
139. Kamekura, S., et al., Osteoarthritis development in novel experimental mouse models 
induced by knee joint instability. Osteoarthritis Cartilage, 2005. 13(7): p. 632-41. 
 
140. Griffin, T.M., et al., Induction of osteoarthritis and metabolic inflammation by a very 
high-fat diet in mice: effects of short-term exercise. Arthritis Rheum, 2012. 64(2): p. 443-53. 
 
141. Mooney, R.A., et al., High-fat diet accelerates progression of osteoarthritis after 
meniscal/ligamentous injury. Arthritis Res Ther, 2011. 13(6): p. R198. 
 
142. Louer, C.R., et al., Diet-induced obesity significantly increases the severity of 
posttraumatic arthritis in mice. Arthritis Rheum, 2012. 64(10): p. 3220-30. 
 
143. Fang, H. and F. Beier, Mouse models of osteoarthritis: modelling risk factors and 
assessing outcomes. Nat Rev Rheumatol, 2014. 
 
144. Glasson, S.S., et al., Deletion of active ADAMTS5 prevents cartilage degradation in a 
murine model of osteoarthritis. Nature, 2005. 434(7033): p. 644-8. 
 
145. Little, C.B., et al., Matrix metalloproteinase 13-deficient mice are resistant to 
osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. 
Arthritis Rheum, 2009. 60(12): p. 3723-33. 
 
146. Amiable, N., et al., Proteinase-activated receptor-2 gene disruption limits the effect of 
osteoarthritis on cartilage in mice: a novel target in joint degradation. J Rheumatol, 2011. 
38(5): p. 911-20. 
 
147. Chen, M., et al., Generation of a transgenic mouse model with chondrocyte-specific 
and tamoxifen-inducible expression of Cre recombinase. Genesis, 2007. 45(1): p. 44-50. 
 
  - 81 - 
148. Henry, S.P., et al., Generation of aggrecan-CreERT2 knockin mice for inducible Cre 
activity in adult cartilage. Genesis, 2009. 47(12): p. 805-14. 
 
149. Zhou, J., et al., Disrupting the Indian hedgehog signaling pathway in vivo attenuates 
surgically induced osteoarthritis progression in Col2a1-CreERT2; Ihhfl/fl mice. Arthritis Res 
Ther, 2014. 16(1): p. R11. 
 
150. Blaney Davidson, E.N., et al., Inducible chondrocyte-specific overexpression of 
BMP2 in young mice results in severe aggravation of osteophyte formation in experimental 
OA without altering cartilage damage. Ann Rheum Dis, 2014. 
 
151. Sah, R.L., et al., Biosynthetic response of cartilage explants to dynamic compression. 
J Orthop Res, 1989. 7(5): p. 619-36. 
 
152. Elliott, D.M., et al., Tensile properties of articular cartilage are altered by 
meniscectomy in a canine model of osteoarthritis. J Orthop Res, 1999. 17(4): p. 503-8. 
 
153. Vincent, T.L., Targeting mechanotransduction pathways in osteoarthritis: a focus on 
the pericellular matrix. Curr Opin Pharmacol, 2013. 13(3): p. 449-54. 
 
154. Mow, V.C., C.C. Wang, and C.T. Hung, The extracellular matrix, interstitial fluid and 
ions as a mechanical signal transducer in articular cartilage. Osteoarthritis Cartilage, 1999. 
7(1): p. 41-58. 
 
155. Ramage, L., G. Nuki, and D.M. Salter, Signalling cascades in mechanotransduction: 
cell-matrix interactions and mechanical loading. Scand J Med Sci Sports, 2009. 19(4): p. 
457-69. 
 
156. Ikura, M., M. Osawa, and J.B. Ames, The role of calcium-binding proteins in the 
control of transcription: structure to function. Bioessays, 2002. 24(7): p. 625-36. 
 
157. Slusarski, D.C. and F. Pelegri, Calcium signaling in vertebrate embryonic patterning 
and morphogenesis. Dev Biol, 2007. 307(1): p. 1-13. 
 
158. Slavov, N., J. Carey, and S. Linse, Calmodulin transduces Ca2+ oscillations into 
differential regulation of its target proteins. ACS Chem Neurosci, 2013. 4(4): p. 601-12. 
 
159. Moore, C., et al., UVB radiation generates sunburn pain and affects skin by activating 
epidermal TRPV4 ion channels and triggering endothelin-1 signaling. Proc Natl Acad Sci U 
S A, 2013. 110(34): p. E3225-34. 
 
160. Eleswarapu, S.V. and K.A. Athanasiou, TRPV4 channel activation improves the 
tensile properties of self-assembled articular cartilage constructs. Acta Biomater, 2013. 9(3): 
p. 5554-61. 
 
  - 82 - 
161. McNulty, A.L., et al., Dynamic loading enhances integrative meniscal repair in the 
presence of interleukin-1. Osteoarthritis Cartilage, 2010. 18(6): p. 830-8. 
 
162. Farndale, R.W., D.J. Buttle, and A.J. Barrett, Improved quantitation and 
discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim 
Biophys Acta, 1986. 883(2): p. 173-7. 
 
163. Stegemann, H. and K. Stalder, Determination of hydroxyproline. Clin Chim Acta, 
1967. 18(2): p. 267-73. 
 
164. Knight, M.M., D.A. Lee, and D.L. Bader, The influence of elaborated pericellular 
matrix on the deformation of isolated articular chondrocytes cultured in agarose. Biochim 
Biophys Acta, 1998. 1405(1-3): p. 67-77. 
 
165. Mauck, R.L., et al., Functional tissue engineering of articular cartilage through 
dynamic loading of chondrocyte-seeded agarose gels. J Biomech Eng, 2000. 122(3): p. 252-
60. 
 
166. Lima, E.G., et al., The beneficial effect of delayed compressive loading on tissue-
engineered cartilage constructs cultured with TGF-beta3. Osteoarthritis Cartilage, 2007. 
15(9): p. 1025-33. 
 
167. Bachrach, N.M., et al., Changes in proteoglycan synthesis of chondrocytes in articular 
cartilage are associated with the time-dependent changes in their mechanical environment. J 
Biomech, 1995. 28(12): p. 1561-9. 
 
168. Buschmann, M.D., et al., Mechanical compression modulates matrix biosynthesis in 
chondrocyte/agarose culture. J Cell Sci, 1995. 108 ( Pt 4): p. 1497-508. 
 
169. Guilak, F., et al., The pericellular matrix as a transducer of biomechanical and 
biochemical signals in articular cartilage. Ann N Y Acad Sci, 2006. 1068: p. 498-512. 
 
170. Haider, M.A., et al., A mechano-chemical model for the passive swelling response of 
an isolated chondron under osmotic loading. Biomech Model Mechanobiol, 2006. 5(2-3): p. 
160-71. 
 
171. Mobasheri, A., et al., Integrins and stretch activated ion channels; putative 
components of functional cell surface mechanoreceptors in articular chondrocytes. Cell Biol 
Int, 2002. 26(1): p. 1-18. 
 
172. Quinn, T.M., et al., Proteoglycan deposition around chondrocytes in agarose culture: 
construction of a physical and biological interface for mechanotransduction in cartilage. 
Biorheology, 2002. 39(1-2): p. 27-37. 
 
173. Lai, W.M., J.S. Hou, and V.C. Mow, A triphasic theory for the swelling and 
deformation behaviors of articular cartilage. J Biomech Eng, 1991. 113(3): p. 245-58. 
  - 83 - 
 
174. Tanaka, N., et al., Cyclic mechanical strain regulates the PTHrP expression in 
cultured chondrocytes via activation of the Ca2+ channel. J Dent Res, 2005. 84(1): p. 64-8. 
 
175. Raizman, I., et al., Calcium regulates cyclic compression-induced early changes in 
chondrocytes during in vitro cartilage tissue formation. Cell Calcium, 2010. 48(4): p. 232-42. 
 
176. Roberts, S.R., et al., Mechanical compression influences intracellular Ca2+ signaling 
in chondrocytes seeded in agarose constructs. J Appl Physiol (1985), 2001. 90(4): p. 1385-
91. 
 
177. Pingguan-Murphy, B., et al., Activation of chondrocytes calcium signalling by 
dynamic compression is independent of number of cycles. Arch Biochem Biophys, 2005. 
444(1): p. 45-51. 
 
178. Hdud, I.M., et al., Expression of Transient Receptor Potential Vanilloid (TRPV) 
Channels in Different Passages of Articular Chondrocytes. Int J Mol Sci, 2012. 13(4): p. 
4433-45. 
 
179. Lewis, R., et al., The role of the membrane potential in chondrocyte volume 
regulation. J Cell Physiol, 2011. 226(11): p. 2979-86. 
 
180. Sanchez, J.C., T.A. Danks, and R.J. Wilkins, Mechanisms involved in the increase in 
intracellular calcium following hypotonic shock in bovine articular chondrocytes. Gen 
Physiol Biophys, 2003. 22(4): p. 487-500. 
 
181. Matthews, B.D., et al., Ultra-rapid activation of TRPV4 ion channels by mechanical 
forces applied to cell surface beta1 integrins. Integr Biol (Camb), 2010. 2(9): p. 435-42. 
 
182. Thodeti, C.K., et al., TRPV4 channels mediate cyclic strain-induced endothelial cell 
reorientation through integrin-to-integrin signaling. Circ Res, 2009. 104(9): p. 1123-30. 
 
183. Goswami, C., et al., Importance of non-selective cation channel TRPV4 interaction 
with cytoskeleton and their reciprocal regulations in cultured cells. PLoS One, 2010. 5(7): p. 
e11654. 
 
184. Nilius, B., et al., TRPV4 calcium entry channel: a paradigm for gating diversity. Am 
J Physiol Cell Physiol, 2004. 286(2): p. C195-205. 
 
185. Burleigh, A., et al., Joint immobilization prevents murine osteoarthritis and reveals 
the highly mechanosensitive nature of protease expression in vivo. Arthritis Rheum, 2012. 
64(7): p. 2278-88. 
 
186. Chang, C.F., G. Ramaswamy, and R. Serra, Depletion of primary cilia in articular 
chondrocytes results in reduced Gli3 repressor to activator ratio, increased Hedgehog 
  - 84 - 
signaling, and symptoms of early osteoarthritis. Osteoarthritis Cartilage, 2012. 20(2): p. 152-
61. 
 
187. Lee, D.A., et al., The influence of mechanical loading on isolated chondrocytes 
seeded in agarose constructs. Biorheology, 2000. 37(1-2): p. 149-61. 
 
188. Bush, J.R. and F. Beier, TGF-beta and osteoarthritis--the good and the bad. Nat Med, 
2013. 19(6): p. 667-9. 
 
189. Walshe, T.E., N.G. dela Paz, and P.A. D'Amore, The role of shear-induced 
transforming growth factor-beta signaling in the endothelium. Arterioscler Thromb Vasc 
Biol, 2013. 33(11): p. 2608-17. 
 
190. Huang, C.Y., P.M. Reuben, and H.S. Cheung, Temporal expression patterns and 
corresponding protein inductions of early responsive genes in rabbit bone marrow-derived 
mesenchymal stem cells under cyclic compressive loading. Stem Cells, 2005. 23(8): p. 1113-
21. 
 
191. Huang, A.H., A. Stein, and R.L. Mauck, Evaluation of the complex transcriptional 
topography of mesenchymal stem cell chondrogenesis for cartilage tissue engineering. Tissue 
Eng Part A, 2010. 16(9): p. 2699-708. 
 
192. Lewis, R., et al., Chondrocyte channel transcriptomics: Do microarray data fit with 
expression and functional data? Channels (Austin), 2013. 7(6). 
 
193. O'Conor, C.J., N. Case, and F. Guilak, Mechanical regulation of chondrogenesis. 
Stem Cell Res Ther, 2013. 4(4): p. 61. 
 
194. Ingber, D.E., Mechanobiology and diseases of mechanotransduction. Ann Med, 2003. 
35(8): p. 564-77. 
 
195. Teichtahl, A.J., et al., Obesity and knee osteoarthritis: new insights provided by body 
composition studies. Obesity (Silver Spring), 2008. 16(2): p. 232-40. 
 
196. Runhaar, J., et al., A systematic review on changed biomechanics of lower 
extremities in obese individuals: a possible role in development of osteoarthritis. Obes Rev, 
2011. 12(12): p. 1071-82. 
 
197. Oliveria, S.A., et al., Body weight, body mass index, and incident symptomatic 
osteoarthritis of the hand, hip, and knee. Epidemiology, 1999. 10(2): p. 161-6. 
 
198. Bastard, J.P., et al., Recent advances in the relationship between obesity, 
inflammation, and insulin resistance. Eur Cytokine Netw, 2006. 17(1): p. 4-12. 
 
199. Griffin, T.M. and F. Guilak, Why is obesity associated with osteoarthritis? Insights 
from mouse models of obesity. Biorheology, 2008. 45(3-4): p. 387-98. 
  - 85 - 
 
200. Rock, M.J., et al., Gain-of-function mutations in TRPV4 cause autosomal dominant 
brachyolmia. Nat Genet, 2008. 40(8): p. 999-1003. 
 
201. Nilius, B. and G. Owsianik, Channelopathies converge on TRPV4. Nat Genet, 2010. 
42(2): p. 98-100. 
 
202. Kochukov, M.Y., et al., Tumor necrosis factor-alpha (TNF-alpha) enhances 
functional thermal and chemical responses of TRP cation channels in human synoviocytes. 
Mol Pain, 2009. 5: p. 49. 
 
203. Denadai-Souza, A., et al., Role of transient receptor potential vanilloid 4 in rat joint 
inflammation. Arthritis Rheum, 2012. 64(6): p. 1848-58. 
 
204. Furman, B.D., S.A. Olson, and F. Guilak, The development of posttraumatic arthritis 
after articular fracture. J Orthop Trauma, 2006. 20(10): p. 719-25. 
 
205. Morikawa, S., et al., Prospective identification, isolation, and systemic transplantation 
of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med, 2009. 206(11): 
p. 2483-96. 
 
206. Diekman, B.O., et al., Intra-articular delivery of purified mesenchymal stem cells 
from C57BL/6 or MRL/MpJ superhealer mice prevents posttraumatic arthritis. Cell 
Transplant, 2013. 22(8): p. 1395-408. 
 
207. Kusudo, T., et al., TRPV4 deficiency increases skeletal muscle metabolic capacity 
and resistance against diet-induced obesity. J Appl Physiol (1985), 2012. 112(7): p. 1223-32. 
 
208. Kimura, T., et al., RECK is up-regulated and involved in chondrocyte cloning in 
human osteoarthritic cartilage. Am J Pathol, 2010. 176(6): p. 2858-67. 
 
209. Dreier, R., Hypertrophic differentiation of chondrocytes in osteoarthritis: the 
developmental aspect of degenerative joint disorders. Arthritis Res Ther, 2010. 12(5): p. 216. 
 
210. Merz, D., et al., IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce 
chondrocyte hypertrophic differentiation. J Immunol, 2003. 171(8): p. 4406-15. 
 
211. Zhu, Z., et al., TRP channels and their implications in metabolic diseases. Pflugers 
Arch, 2011. 461(2): p. 211-23. 
 
212. Levine, J.D. and N. Alessandri-Haber, TRP channels: targets for the relief of pain. 
Biochim Biophys Acta, 2007. 1772(8): p. 989-1003. 
 
213. Barlow, C., et al., Targeted expression of Cre recombinase to adipose tissue of 
transgenic mice directs adipose-specific excision of loxP-flanked gene segments. Nucleic 
Acids Res, 1997. 25(12): p. 2543-5. 
  - 86 - 
 
214. Lau, J., et al., Temporal control of gene deletion in sensory ganglia using a 
tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse. Mol Pain, 2011. 7: p. 100. 
 
215. Fukui, N., C.R. Purple, and L.J. Sandell, Cell biology of osteoarthritis: the 
chondrocyte's response to injury. Curr Rheumatol Rep, 2001. 3(6): p. 496-505. 
 
216. Walton, M., Degenerative joint disease in the mouse knee; histological observations. 
J Pathol, 1977. 123(2): p. 109-22. 
 
217. Glasson, S.S., T.J. Blanchet, and E.A. Morris, The surgical destabilization of the 
medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis 
Cartilage, 2007. 15(9): p. 1061-9. 
 
218. Zhu, M., et al., Tamoxifen-inducible Cre-recombination in articular chondrocytes of 
adult Col2a1-CreER(T2) transgenic mice. Osteoarthritis Cartilage, 2008. 16(1): p. 129-30. 
 
219. O'Conor, C.J., et al., Increased susceptibility of Trpv4-deficient mice to obesity and 
obesity-induced osteoarthritis with very high-fat diet. Ann Rheum Dis, 2013. 72(2): p. 300-4. 
 
220. Zhu, M., et al., Activation of beta-catenin signaling in articular chondrocytes leads to 
osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J Bone Miner 
Res, 2009. 24(1): p. 12-21. 
 
221. O'Conor, C.J., et al., TRPV4-mediated mechanotransduction regulates the metabolic 
response of chondrocytes to dynamic loading. Proc Natl Acad Sci U S A, 2014. 111(4): p. 
1316-21. 
 
222. Itoh, Y., et al., An environmental sensor, TRPV4 is a novel regulator of intracellular 
Ca2+ in human synoviocytes. Am J Physiol Cell Physiol, 2009. 297(5): p. C1082-90. 
 
223. van der Eerden, B.C., et al., TRPV4 deficiency causes sexual dimorphism in bone 
metabolism and osteoporotic fracture risk. Bone, 2013. 57(2): p. 443-54. 
 
224. Loukin, S., et al., Forward genetic analysis reveals multiple gating mechanisms of 
TRPV4. J Biol Chem, 2010. 285(26): p. 19884-90. 
 
225. Zhen, G., et al., Inhibition of TGF-beta signaling in mesenchymal stem cells of 
subchondral bone attenuates osteoarthritis. Nat Med, 2013. 19(6): p. 704-12. 
 
226. Staunton, C.A., R. Lewis, and R. Barrett-Jolley, Ion channels and osteoarthritic pain: 
potential for novel analgesics. Curr Pain Headache Rep, 2013. 17(12): p. 378. 
 
 
